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Abstract
Just as humans communicate with other humans, the cells in our bodies communicate with each
other through various, often complex, mechanisms. Cell-to-cell transmission of small molecules,
lipids, proteins, peptides, or nucleic acids can be mediated by extracellular lipid vesicles called
exosomes. Exosomes have been found to play a role in the delivery of regulatory molecules
from one cell to another, serving as a universal communication mechanism. Currently, there is
an emerging focus on characterizing exosome communication dynamics. Understanding exosome
mechanisms of cell-to-cell communication requires accurate measurements of the spatiotemporal
and chemical dynamics of exosome secretion.

No current analytical approach offers the

appropriate combination of spatial, temporal, and chemical resolutions needed to understand the
dynamics of exosome communication at the tissue or organ level. The research outlined in this
dissertation aims to bridge the gap between bulk fluid analysis of exosome cargo and single cell
visualization of individual exosomes at a single point in time. To achieve better understanding of
the dynamics of exosome secretion, there is a critical need for new analytical technologies. Without
meeting this need, the roles of exosome communication in human health cannot be thoroughly
understood. The long-term goal of this research is to develop tools to characterize communication
between cellular networks, and model mechanisms of disrupted pathways with significance to
neurological disorders. The primary objective is to develop an assay for characterizing temporal
and chemical dynamics of exosome secretion.
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Chapter 1
Introduction

1

1.1
1.1.1

Biological Motivation and Analytical Challenge
Extracellular communication

Our cells communicate through various, often complex, mechanisms. Cellular communication
can be both localized, where cells directly interact with one another, or distant, where various
types of cargos are transported through the extracellular fluid to target cells. Endocrine signaling
occurs when small molecules, lipids or proteins are released from one cell through the bloodstream
often to bind receptors on a target cell, inducing intracellular cascades of response signals [1, 2].
Eukaryotic cells can also release membrane vesicles that transport encapsulated small molecules,
proteins, or oligonucleotides directly to the intracellular space of a recipient cell, providing more
complex routes of communication. Different classifications of extracellular vesicles exist based on
their size and biogenesis. One type of vesicle, known as microvesicles, can be generated by the
budding of the plasma membrane [3]. Apoptotic bodies are other types of vesicles generated by the
random blebbing of the plasma membrane during cellular apoptosis. The smallest classification
of extracellular vesicles is referred to as exosomes, which begin as intraluminal vesicles found
in multivesicular bodies within the cell and are secreted into the extracellular space. For some
diseases, the value may be found in certain proteins or microvesicles. For most diseases, including
various types of cancer, there has been extreme interest and value in studying the secretion and
communication dynamics of exosomes.

1.1.2

Exosome biogenesis

Exosome biogenesis, illustrated in Fig. 1.1, begins with the inward budding of cellular endosomes
called multivesicular bodies (MVBs). MVBs have several possible fates, including fusion with
lysosomes or fusion with the plasma membrane [4, 5]. Fusion with lysosomes results in the
degradation of encapsulated materials, while fusion with the plasma membrane of the cell causes
the release of intraluminal vesicles into the extracellular space [4]. These released vesicles are
called exosomes and they differ from other extracellular vesicles, such as apoptotic bodies or
shedding vesicles, in two key ways. First, exosomes have a narrow size distribution ranging
from 50 - 100 nm in diameter, as compared to the broad 50 nm – 2 µm diameter range of other
2

extracellular vesicles [6]. Second, exosomes often carry specific membrane protein biomarkers,
the most common of which is the tetraspanin CD63 [7, 8]. Early hypotheses that exosome
release is a mechanism only for cellular waste removal were disproved when exosomes originating
from lymphocyte B cells and carrying antigenic peptides were shown to activate T cell immune
responses [9]. This discovery, along with the ubiquity of exosomes in eukaryotic cells, sparked
interest in characterizing the role of exosomes in endocrine communication.

1.1.3

Exosomes as diagnostic biomarkers

The inward budding of cellular endosomes results in the potential for incorporation of various
components found in the cytoplasm [10]. These components may include, but are not limited
to, proteins, lipids, or oligonucleotides. Fusion of MVBs with the cellular membrane facilitates
the release of exosomes containing various types of cargo, under both normal and abnormal
biological conditions. This ability facilitates the transport of important regulatory molecules to
or from specific tissues or organs. Because of their ability to transport regulatory materials from
cell to cell, exosomes may also serve as a vehicle for disease-associated cargo. Exosomes have
recently been identified as potential sources of disease biomarkers due to their diverse range of
encapsulated materials, including various forms of RNA [8, 11]. This is especially promising
since a variety of RNA subtypes regulate gene expression. Small interfering RNA (siRNA) and
microRNA (miRNA) have shown involvement in RNA interference, which silences regulatory
genes and can lead to the progression of disease states [12]. Moreover, sequencing mRNA and
miRNA found in exosomes from a biofluid can help identify the tissue of origin, aiding in accurate
diagnostics. Recently, more attention has been focused on exosomes containing single and double
stranded DNAs, specifically tumor-specific oncogenic mutant DNA [13]. DNA species can also
be present on the surface of exosomes. This is important diagnostics and therapeutics because the
role and function of exosomes is dependent on the originating cell or tissue status [14]. Exosomal
surface proteins, such as tetraspanins, may also be viewed as potential disease biomarkers. For
example, elevated expression of CD81 is associated with severe fibrosis and inflammation, making
it a useful biomarker for the diagnosis and/or treatment of hepatitis C [14]. Based on the variety of
materials that exosomes can transport from one cell to another and the cell type from which they

3

Figure 1.1: Illustration of exosome biogenesis, including generation via inward budding of early
endosomes and release by exocytosis of multivesicular bodies. Potential surface markers and
intracellular contents are also illustrated.

4

were released, the endocrine roles of exosomes are likely broad and are not well understood.

1.1.4

Exosome Characterization

1.1.4.1

Biophysical characterization

There are currently several techniques that have been employed for exosome size characterization.
One approach to characterize the size range of exosomes is nanoparticle tracking analysis (NTA).
NTA is an optical microscopy technique that involves the observation of the displacement of
particles or molecules undergoing Brownian motion by video imaging [15]. Particle movement
can then be correlated to size, concentration, and phenotype [14]. Another method for evaluation
of exosomal size distribution is dynamic light scattering (DLS). The working principle behind
this method is that light passes through a sample of particles suspended in solution. As a result
of the Brownian motion of the particles, the light is scattered and produces scattering intensities
relative to the position of the particles. Time-dependent fluctuations in these scattering intensities
is monitored and the decay rate of the time correlation function is used to ultimately determine
hydrodynamic radius of the particles in solution [16]. DLS offers size determinations of particles
as small as 1 nm [14], rapid analysis times, and a simple sample preparation protocol. However,
the ultimate limitation of DLS is its bias towards larger particles and aggregates, as signal intensity
is proportional to the radius raised to the 6th power according to the Rayleigh approximation [17]:

%Ia =

a6 Na ∗ 100
Na a6 + Nb b6

(1.1)

where Na and Nb are particles with radius a and b, and %Ia is the intensity-weighted distribution for
particles with radius a. Thus, detection sensitivity is limited when characterizing small particles.

High resolution imaging techniques can also be employed for exosomal size characterization.
For example, Transmission Electron Microscopy (TEM) provides structural information through
visualization of size and morphology. Here, a beam of electrons interact with the particle sample
as it passes through, producing secondary electrons and forming an image that is magnified and
focused with special lenses onto an imaging device [14]. The biggest limitation to this method
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is the sample preparation, as samples must be fixed, dehydrated, and placed under vacuum for
imaging. While this technique offers high-resolution visualization of particle diameters and shapes,
electron beams may alter morphology or even damage the sample.

In addition to size and structure, other biophysical properties of exosomes, such as the presence
of surface proteins, may also be characterized by molecular approaches. One common method
for this is flow cytometry, where particles with fluorescent labels are sized based on the degree
of light scattering from a laser source. While conventional flow cytometers do not allow size
detection below 300 nm, newer generations offer improved resolution that allows size detection of
extracellular vesicles, like exosomes, smaller than 300 nm [14].

1.1.4.2

Biochemical characterization

The most common approach to characterizing exosome membrane and intra-vesicular proteins is
mass spectrometry (MS)-based analysis of exosomes purified from bulk biofluids. In this approach,
proteomic signatures are identified by comparing spectra to protein sequence databases [18]. MS
has allowed for extracellular vesicle protein profiling for several diseases, including various types
of cancer [19]. Though MS offers high chemical resolution, the biggest limitation for MS methods
is the bulky instrumentation and required large sample volumes (ca. 10 mL) [20].

An alternate approach for evaluating and quantifying membrane surface and intra-vesiclular
proteins in exosomes is Western blotting. This involves lysis, gel electrophoresis, and transfer to
blotting membrane for protein detection via antibodies [20]. The primary disadvantage with this
technique is the extensive sample preparation, which often hinders reliability and reproducibility
[21].

1.1.5

Analytical Challenge

Though there is a variety of biophysical, molecular, immunoaffinity and microfluidic approaches
to characterize exosomes [22], each technique comes with its own set of limitations for the study of
exosome secretion dynamics at the tissue or organ level with appropriate spatiotemporal resolution.
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The majority of challenges with current techniques stems from the rigorous procedures involved
in isolation and purification of exosomes from bulk fluids. Exosome isolation is challenging due
to their small, specific, and narrow size distribution. The most conventional isolation technique
is ultracentrifugation, which requires multiple cycles of centrifugation steps, high centrifugal
forces, and larger sample volumes [14]. Limitations in sensitivity and limits of detection, as with
MS techniques, necessitate the pre-concentration of exosomes from large volumes of biofluids
by centrifugation techniques [23], ultimately limiting temporal and spatial resolutions. This is
particularly limiting in cell and tissue perfusion experiments, where lengthy perfusion times or
large tissue samples would be needed to collect sufficient quantities of secreted exosomes for mass
spectral analysis. High sensitivity analyses that eliminate the need for exosome purification and
pre-concentration are needed to achieve the spatiotemporal resolution required to understand the
dynamics of exosome communication.

In contrast to the poor spatial resolution of bulk fluid analysis by mass spectrometry,
microscopy can provide subcellular spatial resolution in studying exosome secretion. For example,
high-resolution imaging such as Scanning Electron Microscopy (SEM) and TEM are established
tools for analyzing particle size, morphology, and morphological processes at the single cell
level. Van der Pol et al. evaluated several methods commonly used in single vesicle analysis
and determined that TEM provided the greatest imaging resolution [24]. However, TEM offers
limited chemical resolution, and high spatial resolution comes at the expense of limited imaging
area. Thus, such methods do not offer the appropriate spatial resolution to study populations
of cells together in cultured tissues and are not suitable for characterizing dynamic processes in
living cells. Optical microscopy methods can extend imaging techniques to investigate dynamic
living systems but similarly are limited spatially to a small number of cells. Van der Pol et al.
also discuss exosome characterization challenges inherent in optical techniques, such as nonlinear relationships between exosome size and intensity of scattered light [25]. Studying small
populations of cells by imaging techniques obfuscates emergent properties of tissue and organlevel biological systems. Understanding these emergent properties is essential to determining the
mechanisms of exosome communication that underlie normal and diseased biology.
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Existing techniques allow the identification of exosome contents from bulk fluids, and the
observation of secretion processes at the single cell level, but characterizing the spatiotemporal
dynamics of exosome secretion from complex biological systems, such as primary tissue cultures,
is not readily achieved with current technology. Thus, there is a critical need to bridge the gap of
spatial and temporal scale between bulk fluid analysis of exosome cargo and single-cell imaging
of exosome secretion.

1.2

Liposome application for exosome characterization in solution

1.2.1

Introduction

Previous sections have discussed the biological motivation and importance behind the primary
objective of this dissertation, which is to target exosomes in bulk biological fluids for analysis of
their contents to understand their endocrine roles in cellular communication. Appropriate levels
of spatial, chemical, and temporal resolution for biochemical and biophysical characterization of
exosomes cannot be readily achieved with current technologies. In Chapter 2, exosome content
characterization is explored by the development of an analytical assay that utilizes the safe and
selective delivery of assay reagents to biological exosomes in solution, without the need for
purification. The delivery of assay reagents is facilitated by synthetically prepared lipid vesicles
(liposomes) and is discussed in greater detail in Chapter 2.

1.2.2

Liposome Applications and Preparation

Lipids are composed of polar (hydrophilic) head groups and hydrophobic fatty acid tails. In water,
lipids self-assemble so that the hydrophilic head groups are directed toward the aqueous phase
and the hydrophobic tails are oriented towards each other, forming a fluid-filled, spherical lipid
vesicle, or liposome. Because of their structure, liposomes have the unique ability to encapsulate
and embed various types of molecules, drugs, or nanoparticles. Thus, they are commonly used
as carriers for drug delivery systems and biosensors [26]. Because of this, liposomes have proven
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applications in analytical separations [27, 28, 29, 30], electrochemical biosensors [31, 32, 33, 34],
cosmetics [35, 36, 37], food research [38, 39], pharmaceutics and clinical trials [40, 41, 42], and
much more.

Liposomes are classified based on their size and lamellarity: small unilamellar vesicles (SUVs,
25 – 50 nm), large unilamellar vesicles (LUVs, 100 nm – 1 µm), giant unilamellar vesicles (GUVs,
1 – 200 µm), multilamellar vesicles (MLVs, 0.1 – 15 µm) and multivesicular vesicles (MVVs, 1.6
– 10.5 µm) [26] (Fig. 1.2). The formulation of liposomes is dependent on various techniques
including, but not limited to, thin film hydration, reverse phase evaporation, detergent dialysis,
freeze-thaw, membrane extrusion, heating, and sonication [43]. The selected method used for the
preparation of liposomes described in this dissertation is a combination of freeze-thaw, sonication,
and membrane extrusion.

First, a liposome suspension is prepared via the hydration of a lipophilic powder. In solution,
lipids spontaneously form a heterogenous mixture of liposomes. To reduce lamellarity and induce
encapsulation, freeze-thaw cycling is performed. This method involves freezing the liposome
solution with a dry ice bath or liquid nitrogen followed by thawing at a temperature higher than
the lipid phase transition temperature [44, 45]. During this process, freezing disrupts the lipid
bilayer and thawing induces vesicle fusion, resulting typically in large unilamellar vesicles. Large,
multilamellar lipsomes can be disrupted to produce small, unilamellar liposomes (ca. 15 - 50
nm in diameter) by sonication. To prepare liposomes of a specific size, membrane extrusion is
then performed. This method involves passing the liposome solution through a porous membrane
with defined pore size ranging from low nanometer to micrometer diameters. After several passes
through the membrane, a homogenous solution of liposomes is produced.
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Figure 1.2: Illustration of size and lamellarity of the different classifications of liposomes.
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1.2.3

Analytical Challenges

The preparation and application of liposomes encapsulating analytical reagents will facilitate
selective detection of exosome membrane proteins and high sensitivity detection of exosome
contents. Chapter 2 discusses a model system used for molecular recognition-driven vesicle fusion
and the analytical challenges that arose from preliminary experiments. As the chapter summary
highlights, the main challenge for the developed system involved the inability to fully understand
our system. This redirected focus to making size-based characterizations of low-volume samples.

1.3

Taylor dispersion analysis for high sensitivity size characterization

Dynamic light scattering (DLS) and size exclusion chromatography (SEC) are gold standard
methods for size characterization of macromolecules and particles.

However, both warrant

analytical challenges for characterizing the size of low-volume, low-concentration biological
samples. In Chapters 3 and 4, the need for more accurate, sensitive, and straightforward tools
for size characterization is discussed in depth. Taylor dispersion analysis, a promising analytical
tool for size characterization, is reviewed extensively in Chapter 3, and the development of a 3D
printed instrument for TDA is presented in Chapter 4.

1.3.1

Theory

Taylor dispersion analysis (TDA), first described in 1953 [46], enables direct determination of
molecular diffusion coefficients across a wide dynamic range of hydrodynamic radii. TDA is
advantageous over the more common sizing methods described above because it requires no
calibration, purification, or knowledge of sample concentration [47]. Furthermore, TDA can be
performed within small diameter fused silica capillaries, requiring only sub-nL sample volumes.
Taylor dispersion itself is a phenomenon that occurs under well controlled pressure driven laminar
flow where molecules of different size behave differently within the parabolic velocity profile. An
injected sample plug spreads out axially, which is observed by band broadening. The behavior
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of the analyte and degree of band broadening that results is directly related to its size. It is
important to note that TDA is conducted under well-controlled flow conditions in which only
band broadening from radial diffusion is considered and contributions from longitudinal diffusion
is neglected. The first flow condition requires the rate of advection to be substantially greater than
the rate of diffusion, which is satisfied when the Peclet number (P e) is greater than 69 [48], defined
by the following equation [49]:
Pe =

uRc
D

(1.2)

where u is the linear flow rate, Rc is the radius of the capillary, and D is the molecular diffusion
coefficient. The second flow condition requires the sample to remain in flow long enough to
observe sufficient band-broadening due to Taylor dispersion [46]. This condition is satisfied when
τ > 1.4, where τ is defined as:
τ=

DtR
Rc2

(1.3)

where tR is the requisite residence time of the sample plug in flow. If two detection points are
employed, band broadening under continuous flow can be compared and D can be determined by
[50]:
Rc2 (t2 − t1 )
D=
24(σ22 − σ12 )

(1.4)

where t1 and t2 are the peak arrival times at detectors 1 and 2, respectively, and σ12 and σ22 are the
peak variances as observed at detectors 1 and 2, respectively. From here, D can be transformed to
hydrodynamic radius (RH ) by the Stokes-Einstein relation [51]:
RH =

kB T
6πηD

(1.5)

where kB is the Boltzmann constant, T is temperature, and η is the dynamic viscosity of the
solution.
Principles, practical considerations, and applications of TDA are discussed in greater detail in
Chapter 3.
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1.3.2

Detection modes

1.3.2.1

UV-Vis absorbance

The most common detection mode used for TDA has been UV-Vis absorbance. For absorbance
detection, a continuous light source, such as a deuterium, hydrogen, or halogen lamp, with power
P0 is directed through a detection cell or window. The intensity of light transmitted is reduced to P
and used to calculate the absorbance of the sample solution. There is a linear relationship between
the sample’s concentration (c) and corresponding absorbance (A), given by Beer’s law [52]:

A = −log(T ) = log(

P0
)=εbc
P

(1.6)

where T is transmittance, ε is molar absorptivity, and b is the pathlength of the detection cell or
window.
Absorbance detection is advantageous due to its versatility to a variety of molecules that absorb
at a specified wavelength, label-free. However, label-free detection modes are inherently less
selective, which could be disadvantageous when analyzing mixtures or analytes that have broad
absorbance spectra. Another major disadvantage for absorbance detection in this setting is the
pathlength, which is dependent on capillary diameter (typically 25 - 100 µm). According to Beer’s
law, absorbance decreases with pathlength. Additionally, absorbance is also proportional to sample
concentration. Thus, absorbance detection modes often lead to sensitivity issues when analysis of
low concentration samples is desired.

1.3.2.2

Fluorescence detection

For improved sensitivity and selectivity of target molecules, fluorescence detection has been
employed for TDA, yet is not a widely adopted detection mode for this technique. Fluorescence
methods typically use light sources that are monochromatic or highly tunable, such as mercury
lamps, light-emitting diodes (LEDs), and lasers. These more intense light sources are necessary to
provide a high number of photons with the specific wavelengths needed to induce fluorescence of a
molecule. During fluorescence, high energy photons excite the electrons of a fluorescent molecule
from their native ground state to a higher energy excited state upon absorbance. These electrons
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lose vibrational energy and emit secondary photons at a lesser energy and longer wavelength on
their way back down to the ground state. Unlike absorbance detection, fluorescence detection
allows specificity by targeting a specific fluorescent molecule with its excitation wavelength.
Fluorescence signal intensity can be dependent on the photophysical properties of the molecule,
such as quantum yield [53]. Fluorescence quantum yield (Φ) is described by the ratio of emitted
photons to absorbed photons:

Φ=

emitted photons
absorbed photons

(1.7)

Along with quantum efficiency, fluorescence intensity (F ) is dependent on power of the excitation
beam absorbed by the molecule, estimated by [52]:

F ≈ φ (P0 − P )

(1.8)

where P0 is the incident beam power and P is the power after transmittance. Substituting a form
of Beer’s law into this approximation equation, we get

F ≈ φ A P0 ≈ φ  b c P0

(1.9)

where A is absorbance,  is molar absorptivity, b is pathlength, and c is concentration. From this it
is apparent that fluorescence intensity is also directly proportional to the sample concentration and
the pathlength of the system.

Of the existing excitation sources, laser-induced fluorescence (LIF) detection is most easily
adaptable to small pathlength systems, such as capillaries or microfluidic devices, as laser beams
exhibit low divergence and are easily focused on small detection volumes with high irradiation
[54]. Because of this, LIF limits of detection are lower than most other detection systems.

A primary benefit of fluorescence detection over absorbance detection is its high sensitivity
resolution in low background noise. However, background signal can still potentially dominate, for
example, via scattered excitation. In order to maximize signal-to-noise ratio, careful consideration
must be made to reject sources of background via optical filtering. For a simple fluorescence
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detection system, a bandpass filter is needed to collect the desired emission wavelength while
blocking wavelengths that lie outside its range. Despite this effort, small percentages of unwanted
light can still be transmitted through the filter and collected by the detector, contributing to
background. The relative amount of light able to pass through a filter can be described by a
property of the filter called optical density (OD). The OD value of a filter indicates how much
optical power is reduced from the light source and is related to transmission (T) by [55]
1
OD = log10 ( )
T

(1.10)

T = 10−OD

(1.11)

or

where T represents a percentage. The higher the OD value, the less transmittance of wavelengths
outside of the filter range. Nonetheless, further filtering can add to the efforts of rejecting excess
background. If ever the background noise is substantial enough to exceed the dynamic range of
the detector, a neutral density (ND) filter can be added to reduce the overall intensity of light
reaching the detector. A common source of background is Raman scatter of the buffer or solvent.
To reduce this contribution, short-pass or long-pass filters can be incorporated, so long as Raman
scatter is being blocked and the desired emission wavelength is accepted. With the addition of the
above mentioned filters, wavelengths outside of the bandpass filter wavelength range and Raman
scattering are highly attenuated, but laser scatter may still be a significant hindrance. To reject
excess laser scatter, a high OD notch filter can be added to filter out the wavelength specific to the
laser. This also reduces background by reducing the shot noise and flicker noise associated with a
laser source [53]. Additionally, spatial filtering methods may also be used in order to attenuate the
beam of the laser source to reduce scatter.

1.3.3

TDA instrumentation

TDA instrumentation primarily involves a capillary with one or two detection regions and a
flow source. Currently, there are few automated capillary systems commercially available that
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have sizing capabilities based on Taylor dispersion. The Viscosizer TD (Malvern Panalytical)
and the Fida 1 (Fidabio) are two popular instruments, which operate using Poiseuille’s law and
Taylor dispersion to separately determine viscosity and hydrodynamic radius. To make these
measurements, the Viscosizer TD has been reported to use 7 µL per injection for samples ranging
from 2 - 5 mg mL−1 [56]. Despite the availability of these automated systems, TDA is most
commonly performed within capillary electrophoresis (CE) instrumentation. This is primarily
due to the reduced analysis times, improved precision of flow rate control, and low sample
consumption. The evolution of TDA towards commercial CE instrumentation has presented several
engineering challenges, including the integration of dual-point detection. Though there have been
some advances to address these challenges [57, 58], the use of CE instrumentation for TDA is also
limited to the expense of additional detection modes aside from routine UV-Vis absorbance. While
it is most common for TDA to be performed using UV-Vis absorbance, TDA can also be coupled to
other detection modes such as fluorescence detection [58], mass spectrometry [59, 60], refractive
index [61], and backscattering interferometry [62].

Ultimately, TDA can be easily and simply implemented into a variety of scientific studies,
which may be acquiescent to the development of low-cost, open-source hardware that will enable
adoption of this analytical method. To deliver improved instrumentation for performing TDA in
capillaries, the development and optimization of a 3D printed TDA instrument is discussed later in
Chapter 4.

1.3.3.1

3D printing

3D printing has emerged as a transformative manufacturing and fabrication tool for countless
applications. The process involves printing complex structures and geometries one layer at a time
using a variety of methods, materials, and equipment [63]. The ability to fabricate customized
products often with complex geometries at a low cost makes 3D printing desirable for various
industries such as construction, dentistry, biomedical, microfluidics. Some common methods for
3D printing include: fused deposition modelling (FDM), selective laser sintering (SLS), inkjet
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printing, and stereolithography (SLA).

Developed in 1986, SLA is the earliest commercially available solid freeform technique [64],
and is the selected 3D printing method used in this research. Stereolithography uses UV-light to
locally polymerize and solidify UV-active acrylic or epoxy-based resin layer-by-layer. Depending
on the apparatus, a laser beam or LCD screen patterns the structure to a build platform from the
bottom up. Once the first layer is UV-cured to the platform, the next layer is patterned and cured
to the first, until the 3D structure is complete. While most fabrication techniques offer resolution
between 50 - 200 µm, commercial SLA products allow fabrication down to 20 µm and even subµm for two-photon initiation setups [64].

1.3.4

Immunoassays

One primary application of the developed assay for exosome characterization outlined in Chapter 2
and the TDA instrument described in Chapter 4 is the utility of immunoassays for highly selective
detection of exosome membrane proteins. Molecular recognition of exosome membrane proteins
will likely be carried out with antibody-conjugated liposomes. Additionally, selective targeting
of exosome membrane proteins via antibodies can be monitored by TDA with the developed
instrument. These potential avenues will be explored and discussed in more detail in Chapter
5.

1.3.4.1

Principles

The basic principle behind an immunoassay is based on the highly specific molecular recognition
of antigens and antibodies [65], and the corresponding reversible binding reaction. Here, the
antibody binds to the antigen to form an immunocomplex. Types of immunoassays can be broken
down into labelled and unlabelled assays, depending on the measurability of the binding reaction
[66]. For a labelled immunoassay, either the free antibody or antigen is labelled and measured
against the formed immunocomplex. Selecting which species to label depends on the desired
measurement or technique used for detection and quantification, and can be broken down into
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competitive and non-competitive systems.

1.3.4.2

Competitive vs Non-competitive

In competitive immunoassays, the unlabelled target antigen competes with a labelled similar
antigen to bind the same antibody. Once an equilibrium is reached, the amount of bound, labelled
immunocomplex is inversely proportionate to the concentration of the unlabelled, target antigen
present in the sample [67]. This concept can be described by the following:
Ag∗ + Ag + Ab

Ag

Ab + Ag∗

Ab + Ag∗ + Ag

(1.12)

where Ag is the antigen, Ab is the antibody, and * is the label (Fig. 1.3A).
In non-competitive immunoassays, an excess amount of labelled antibody binds the target
antigen and forms a bound, labelled immunocomplex. Here, the amount of bound, labelled
immunocomplex is directly proportionate to the concentration of target antigen in the sample [67].
This concept can be described by the following:
Ag + Ab∗

Ag

Ab∗

(1.13)

where Ag is the antigen, Ab is the antibody, and * is the label (Fig. 1.3B).

1.3.4.3

Introduction to TDA Immunoassays (TDA-IA)

Though there are no specific molecular biomarkers that distinguish exosomes from other extracellular vesicles, exosome membranes are often enriched with certain tetraspanin proteins, the most
common of which are CD9, CD63, and CD81 [13]. Thus, they can be utilized for the detection
and quantification of exosomes via the combination of TDA and an immunoassay (TDA-IA).

The average immunoglobulin G (IgG) antibody, found in blood, is approximately 5 - 6 nm in
hydrodynamic radius [68, 69] while the exosomes we are interested in measuring are around 25 50 nm in hydrodynamic radius, and the expected radius of the immunocomplex is similar to

18

Figure 1.3: Illustration of competitive vs non-competitive immunoassays.
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that of the exosomes (ca. 25 - 55 nm). Thus, the proposed immunoassay will employ the noncompetitive format, where the antibody is labeled and the amount of exosomes (antigen) can be
directly measured based on the amount of formed antibody-exosome complex. This format offers
an advantage over a competitive format because a distinct difference in size measurements can be
made from free, labeled antibody and bound, labeled complex. If the competitive format were
employed, there would be a need for distinguishing between two species of similar hydrodynamic
radius (free exosome vs antibody-exosome complex). Thus, the concept of this TDA-IA involves
size characterizations of a sample of a fluorescently labeled antibody specific to one of the
above mentioned exosome membrane proteins and of this antibody added to a sample of purified
exosomes.

Further discussion of this TDA-IA is included in Chapter 5.3. There, a potential design of
experiments will be outlined and preliminary data will be provided.

1.4

Conclusion

This chapter provides an introduction to the biological background and motivation of this research,
analytical challenges, and methodology used in the following chapters. The concepts described
above will work together towards a common research goal: developing cost-effective analytical
tools that allow the characterization of exosome size and contents without the need for purification
in limited volume, low concentration biological samples. In Chapter 2, an outline of the progress
made towards this goal will be described, while a description of analytical challenges that arose will
be given. In Chapter 3 we review fundamental principles and progress in the area of TDA, since this
technique forms an important part of our approach to circumvent the challenges described in the
previous chapter, as well as to contribute to current size characterization technologies. In Chapter
4, the development of a 3D printed instrument for performing TDA in fused silica capillaries is
discussed. Finally, Chapter 5 will conclude this dissertation with a discussion of future work that
is needed to progress the research. Preliminary results for future work will also be presented and
discussed.
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Chapter 2
Towards Development of Fluorescence Assays in a Model of Molecular Recognitiondriven Vesicle Fusion
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2.1

Abstract

The primary limitation in current approaches in exosome isolation and purification is the inability
to distinguish between other extracellular vesicles and molecules in biological fluids. Additionally,
membrane proteins that commonly enrich the surface of exosomes cannot be used as universal
biomarkers for exosomes. More accurate methods and tools for characterization of exosome
contents is necessary for understand their communication dynamics. This chapter describes the
development of a novel analytical assay utilizing synthetic lipid vesicles to deliver assay reagents
to exosomes in bulk biofluids, without the need for purification. Preliminary work is provided and
discussed, as well as potential pitfalls and how they may be remedied.

2.2

Introduction

The importance of establishing a universal, reliable, and reproducible isolation and characterization
method for exosome research has been discussed. The greatest limitation in current approaches in
exosome isolation is the inability to distinguish between the different populations of extracellular
vesicles (i.e. exosome, apoptotic bodies, microvesicles, etc.) with diameters less than 200 µm
[1]. Because of this limitation, analyses are typically performed on these extracellular vesicles,
rather than a purified population of exosomes. An added dimension of distinguishing between
exosomes and other small extracellular vesicles is the targeting of specific tetraspanin proteins
(most commonly CD63, CD81, and CD9) as identifying biomarkers [1]. It is important to note
that these proteins are also expressed on the surface of the cell and other types of extracellular
vesicles, and are also not present in all exosomal membranes. Thus, a single biomarker does
not exist to selectively identify an exosome from all other vesicles. Because of these limitations,
there is currently no established isolation method for exosomes from other extracellular vesicles
of similar size or biological components of similar composition. A more accurate method for
exosome isolation and characterization would provide a better understanding of the endocrine roles
of exosomes, further aiding diagnostic and therapeutic applications [2].
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2.2.1

Research Objective

Eliminating the need for purification of exosomes from bulk biological fluid poses the challenge
of distinguishing between molecules that are encapsulated by exosomes and un-encapsulated
molecules of similar composition that are present in the extracellular environment. To address
this challenge, we propose a mechanism for the delivery of exosome contents to the intraluminal
volume of synthetic lipid vesicles that encapsulate assay reagents. Analytical assays can take place
within the encapsulated volume without interacting with extracellular molecules. The success of
this approach will depend on optimized assay conditions and the efficacy of molecular recognition
and detection modes. These factors will serve as the basis for the development of fluorescence
assays in a model of molecular recognition-driven vesicle fusion. This assay will utilize the fusion
of exosomes with synthetically prepared lipid vesicles that encapsulate analytical reagents. Vesicle
fusion can facilitate encapsulated analytical reactions and high sensitivity detection of vesicle
contents. Small unilamellar vesicles (SUVs) with diameters on the order of 10 - 100 nm readily
fuse with one another to reduce energetic strain caused by the high degree of membrane curvature.
When the vesicles fuse, their contents mix, enabling analytical reactions to assay encapsulated
biomolecules. This system can be functionalized for molecular recognition of exosome membrane
proteins, offering specificity for assaying exosome contents. Vesicles can be prepared synthetically
to encapsulate, for example, fluorescamine, which reacts with primary amines to form a fluorescent
product. Thus, when the synthetic vesicle and exosome fuse, directed by molecular recognition
processes, their contents mix and produce a quantitative fluorescence signal.

2.2.2

Spontaneous Vesicle Fusion

For two vesicle membranes to fuse, they must be brought into close proximity, make initial contact,
and have enough energy to overcome the fusion energy barrier [3]. A vesicle’s inclination to fuse
with another vesicle or membrane is dependent on lipid composition and the surface curvature at
the point of contact [4]. Vesicle curvature is dependent on diameter, as smaller diameter vesicles
(i.e. 50 nm) have greater surface curvature and a higher energy strain than larger diameter vesicles
(i.e. 1 µm). In a study of vesicle fusion simulation models, Smeijers et. al observed that the
connection between two vesicles (large or small) was made when the intervesicle distance was
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between 1.3 - 1.7 nm [4]. After initial contact, spontaneous fusion is initiated by one of several
accepted pathways. One pathway, deemed the stalk-pore hypothesis, suggests that the outer
monolayer of the vesicles form a stalk, which expands radially to connect the inner monolayer
of the vesicles [5]. A fusion pore is formed and grows until fusion is complete. Other hypotheses
argue over the simultaneous versus independent formation of the stalk and fusion pore.

2.3
2.3.1

Preliminary Development
Design of model system

The primary objective of this research was to analyze exosome contents by safely delivering
synthetic vesicles that encapsulate assay reagents to exosomes in situ. This system was modeled
by preparing two sets of vesicles that encapsulate analytical reagents that mix to produce a
measurable signal upon vesicle fusion. The design of the model system addresses two key points:
modelling molecular recognition and modelling detection. Molecular recognition of exosomal
surface proteins, with antibodies or other molecular recognition approaches, were modeled by
exploiting the strong protein-ligand interaction of a biotin-avidin complex. Avidin is a protein
derived from eggs of oviparous vertebrates [6] that has 4 binding domains and a strong affinity to
biotin. To prepare vesicles for molecular recognition, lipids with biotinylated head groups were
incorporated into the vesicle membrane. An avidin molecule was then able to bind up to four
biotin-conjugated vesicles. The biotin-avidin interaction facilitated driving the bound vesicles to
close proximity and high vesicle surface tension induced fusion. To model detection of potential
exosomal contents, the vesicles were prepared to encapsulate two separate assay reagents to
produce a fluorescent signal once combined. It is known that exosomes may contain specific RNA
subtypes [7, 8], and single- and double-stranded DNA [1], thus the selected model assay reagents
include DNA and an intercalating dye. When combined, SYBR green intercalates and binds the
minor groove of the DNA backbone. As a result, a fluorescent signal (λex = 497 nm, λem = 520
nm) was observed. The complete model system consisted of two prepared sets of vesicles. SUVs
with diameters of 50 nm were prepared with encapsulated salmon sperm DNA; these are referred
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to here as exosome models (EM). SUVs with 100-200 nm diameters encapsulating the DNAintercalating fluorescent dye SYBR green are referred to here as reagent vesicles (RV). Formation
of RV-avidin-EM complexes brings vesicles into close proximity, promoting spontaneous vesicle
fusion. When vesicles fuse, their contents mix, enabling analytical reactions to assay encapsulated
biomolecules (Fig. 2.1). This system can be modified for molecular recognition of biologically
derived exosomes, offering specificity for assaying exosome contents.

2.3.2

Reagents and sample preparation

A model system of exosome molecular recognition and vesicle fusion has been developed. Giant
multilamellar vesicles (GMVs) that encapsulate assay reagents were formed by the freeze-thaw
method using a buffered aqueous solution (TBS) containing DOPC (20 mg mL−1 ), 1% w/w
Biotinyl cap-PE (25 mg mL−1 ), and assay reagents. GMVs were converted to SUVs with specific
diameters by membrane extrusion. Vesicle solutions were then purified by size exclusion columns
with Sephadex G50 media.

2.3.3

Results

Early progress has been made towards the long-term goal of optimizing several experimental
variables in the model system, including choice of analytical reagents, vesicle diameter, purification methods, and concentration of added avidin. In the proximity vesicle fusion assay,
measured signal depends on the type of chemical reaction utilized. Initially, a chemiluminescencebased approach was selected to provide high signal-to-noise ratios and therefore low limits of
detection compared to, for example, a fluorescence quenching assay. The chemiluminescence
reaction involved three reagents: luminol, horse radish peroxidase (HRP), and hydrogen peroxide.
Since only two vesicle populations are prepared in the assay, two of the reagents had to be
encapsulated together. This presented several challenges, such as encapsulation inefficiency and
undesired reaction between co-encapsulated reagents. Since the experimental setup included a
high sensitivity photon-counting photomultiplier tube (PMT) and changes in light intensity were
being measured, difficulty in creating an appropriately dark workspace arose, resulting in excess
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Figure 2.1: EMs (50 nm) are synthetically prepared to encapsulate salmon sperm DNA while
RVs (100-200 nm) are synthetically prepared to encapsulate SYBR green. Addition of avidin
drives biotin-labeled vesicles together (i). Direct contact initiates vesicle fusion (ii). Vesicle fusion
results in content mixing and fluorescent signal for detection (iii).
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background noise from stray light. To address these challenges a fluorescence-based approach was
devised in which only two reagents are needed, and spectral resolution can be used to reduce the
magnitude of collected stray light.

Fluorescence measurements were carried out within a polystyrene 96-well plate positioned on
the stage of an inverted epifluorescence microscope (Eclipse Ti-U, Nikon, Newton, NJ), equipped
with an LED excitation source (DC2200, Thorlabs, Newton, NJ), and photon counting PMT
(H7828-50, Hamamatsu, Hamamatsu, Japan). Changes in fluorescence intensity were collected via
LabView (National Instruments, Austin, TX). Two populations of synthetic vesicles were prepared,
EMs encapsulating salmon sperm DNA (2 mg mL−1 ) to model exosome oligonucleotide content,
and RVs encapsulating SYBR green, a concentration-sensitive oligonucleotide intercalating
fluorescent dye.

Due to challenges in quantifying EMs and RVs in purified solution, all

experiments were conducted using aliquots from the same purified RV and EM solutions in the
same ratios. These were each purified by centrifugation, and 30 µL each of purified EM and RV
solutions were added together into a single well giving an increase in background fluorescence
signal which may be due to the carryover of small quantities of unencapsulated DNA and SYBR
Green or spontaneous vesicle fusion/lysis (Fig. 2.2A, t = 10s). While measuring fluorescence
intensity (λex = 482 ± 9nm, λem = 520 ± 12nm), 30 mL of avidin (100 µM ) was added
(Fig. 2.2A, t = 180s) and the fluorescence intensity monitored versus time (Fig. 2.2B). Upon
addition of avidin, fluorescence intensity increased, suggesting proximity-induced vesicle fusion
and content mixing. A series of control experiments (Fig. 2.2C) were performed to demonstrate
that increased fluorescence intensity is not the result of avidin (shown in green) or the independent
combination of EVs with avidin (red) or RVs with avidin (black).

2.4

Discussion

Though an increase in fluorescent signal was observed upon the addition of avidin to the EM and
RV mixture, there are several analytical challenges that arise due to the sample preparation and
purification approaches. The major limiting step in our procedure is the purification of vesicles
via centrifugation. First, vesicles were prepared by freeze-thaw cycles to encapsulate the assay
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reagents (i.e. DNA and SYBR green). The vesicles underwent several wash steps involving
water, chloroform, and methanol before centrifugation. Centrifugation of the suspension formed
a pellet, and the supernatant was removed and replaced with fresh buffer repeatedly to remove
any unencapsulated material. This is potentially problematic because the procedure is similar to
ethanol precipitation, a commonly used technique for concentrating and desalting nucleic acid
preparations in aqueous solutions. Thus, the formed pellet from centrifugation could contain any
unencapsulated DNA. If there is also any unencapsulated SYBR green in our second population of
prepared vesicles, contribution to the fluorescent signal could be observed from unencapsulated
DNA-SYBR green interactions.

Furthermore, SYBR green is membrane-permeable, as its

structure contains a positive charge and hydrophobic aromatic rings [9]. Thus, SYBR green has the
potential to permeate back into the buffer environment, embed in the membrane of the vesicles, or
even permeate through the membranes and into an adjacent vesicle containing DNA. This would
contribute fluorescent signal to leakage and/or vesicle aggregation.

Understanding the conditions of our model system is crucial in proceeding with the development of our assay.

We must be able to make characterizations that help distinguish

between vesicle fusion (Fig. 2.3a), aggregation (Fig. 2.3b), or content leakage (Fig. 2.3c). One
distinctive characteristic of these different system configurations is size. Thus, a highly sensitive
analytical method for making size-based determinations from low-volume samples is necessary in
understanding the status of our proposed analytical assay.

2.5

Conclusion

The work described in this chapter focuses on early progress made towards developing a novel
assay for exosome analysis without the need for purification and with the potential for detecting
exosome contents without getting interactions from other extracellular vesicles or molecules of
similar composition. A proximity vesicle fusion assay was proposed with the central hypothesis
that vesicle fusion combined with molecular recognition of exosome membrane proteins can
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Figure 2.2: A) Fusion and fluorescence demonstration upon avidin addition to reagent vesicles,
B) reproducibility of signal increase, and C) graph of control experiments, where signal increase
is not due to avidin or the combination of assay vesicles with avidin.
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facilitate encapsulated analytical reactions and high sensitivity detection of vesicle contents,
enabling specific assay of biomolecules encapsulated by exosomes. Early progress was made
towards the development of a model system of exosome molecular recognition and vesicle
fusion using synthetically prepared lipid vesicles encapsulated with analytical reagents. However,
efficiency with which reagents remained encapsulated within lipid vesicle reagent carriers
presented a challenge to assay sensitivity, proving difficulty in isolating which variables were
contributing to signal. This significant analytical challenge allowed us to look at our system from
a new perspective—to make size-based determinations so that we could observe vesicle fusion,
aggregation, or leakage, each phenomenon arising from a different composite state of the vesicle
system resolvable by hydrodynamic radii. This presented a critical need for the development of a
sensitive, selective, and straightforward analytical tool for characterizing the state of the proximity
vesicle fusion assay. Chapters 3 and 4 describe the fundamental principles of size characterization
by TDA, and the development of a 3D-printed instrument for the size-based characterization of
lipid vesicles.
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Figure 2.3: An illustration of potential avenues for observed fluorescence signal: (a) Fusion
and fluorescence upon avidin addition, (b) fluorescence signal due to vesicle aggregation, and
(c) fluorescence signal due to leakage of assay contents.
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3.1

Abstract

Biological and pharmaceutical analytes like liposomes, therapeutic proteins, nanoparticles, and
drug-delivery systems are utilized in applications, such as pharmaceutical formulations or
biomimetic models, in which controlling their size is often critical.

Many of the common

techniques for sizing these analytes require method development, significant sample preparation,
large sample quantities, and lengthy analysis times. In other cases, such as DLS, sizing can be
biased towards the largest constituents in a mixture. Therefore, there is a need for more rapid,
sensitive, accurate, and straightforward analytical methods for sizing macromolecules, especially
those of biological origin which may be sample-limited. Taylor dispersion analysis (TDA) is a
sizing technique that requires no calibration and consumes only nL - pL sample volumes. In
TDA, average diffusion coefficients are determined via the Taylor-Aris equation by characterizing
band broadening of an analyte plug under well-controlled laminar flow conditions. Diffusion
coefficient can then be interpreted as hydrodynamic radius (RH ) via the Stokes-Einstein equation.
Here, we offer a tutorial review of TDA, intended to make the method better understood and
more widely accessible to a community of analytical chemists and separations scientists who may
benefit from the unique advantages of this versatile sizing method. We first provide a tutorial on
the fundamental principles that allow TDA to achieve calibration-free sizing of analytes across a
wide range of RH , with an emphasis on the reduced sample consumption and analysis times that
result from utilizing fused silica capillaries. We continue by highlighting relationships between
operating parameters and critically important flow conditions. Our discussion continues by looking
at methods for applying TDA to sample mixtures via algorithmic approaches and integration of
capillary electrophoresis and TDA. Finally, we present a selection of reports that demonstrate TDA
applied to complex challenges in bioanalysis and materials science.
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3.2

Introduction

Designing and producing drug delivery systems, therapeutic proteins, nanoparticles, and biopolymers requires fast and straightforward characterization of these products via high accuracy and high
sensitivity analytical methods. Many standard methods for solution-phase size characterization
require extensive method development, tedious sample preparation, large sample volumes, lengthy
analysis times, and/or expensive instrumentation. One widely used size characterization method
is dynamic light scattering (DLS), which can, in some cases, be performed with limited sample
preparation and offer rapid analysis times. Complex samples such as blood plasma have been
analyzed by DLS with preparation as simple as dilution, filtration and/or centrifugation [1, 2].
However, signal intensity in DLS is proportional to the analyte radius raised to the 6th power [3],
which makes detection sensitivity particularly challenging when characterizing small particles.
For the same reason, DLS is sensitive to issues of analyte aggregation [3]. These qualities are
often disadvantageous when interrogating the size of small proteins, especially in the presence
of larger proteins or aggregates. Hawe et al. measured a range of concentrations (0.05 – 50
mg mL−1 ) of various peptides and proteins [4]. While DLS accurately sized the antibody drug
adalimumab (5 - 6 nm) at the lowest concentration, sizing the peptide oxytocin ( 0.8 nm) was
not possible at low concentrations due to the influence of dust or excipients in the sample. In
this case, DLS provided inaccurate and inconsistent hydrodynamic radius (RH ) determinations for
oxytocin ranging from 6.9 – 130 nm. In the same work, DLS was utilized to observe aggregation
in heat-stressed formulations of protein samples. With a 5°C increase in temperature, a model IgG
antibody showed an increase from RH = 7.5 nm to RH = 22 nm by DLS, whereas TDA measured a
modest increase from RH = 6.5 nm to RH = 7.5 nm under identical conditions. This disagreement
was attributed to the bias of DLS towards large particles, in which the largest particles or aggregates
dominate the overall scattering intensity, thus resulting in inaccurately high RH determinations.

Size exclusion chromatography (SEC) is another method often employed for size determination. SEC requires precise calibration with appropriate size standards, and is susceptible to
deleterious effects of analyte-column interactions [5]. Pacáková et al. found that melittin, a
strongly basic peptide found in bee venom, displayed deleterious retention on a hydrophilic SEC
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column, which they attributed to the peptide’s inability to form a predominantly hydrophilic shell
due to the uneven distribution of exterior hydrophilic residues [6]. Overcoming these deleterious
analyte-column interactions required method optimization such as the addition of an organic
solvent to the mobile phase and pH optimization. Ricker et al. explain that SEC columns can
exhibit electrostatic effects when the mobile phase ionic strength is low, and hydrophobic effects
when ionic strength is high [7]. Either case can result in deleterious retention of analytes, which
can result in peak deformation and, ultimately, inaccuracy of size determinations by SEC. They
observed the effect of mobile phase ionic strength on SEC of three mouse myeloma antibodies
using a silica-based stationary phase material. At low ionic strength, the least basic antibody
had no net positive charge, and was therefore unaffected by adsorption to the anionic silanols at
the stationary phase surface. However, at high ionic strength, the antibody was retained due to
hydrophobic effects. This work demonstrates the careful consideration for method development
that is needed for accurate size determinations by SEC.

Various micro- and nanoscopic imaging techniques such as transmission electron microscopy
(TEM), scanning electron microscopy, and atomic force microscopy have been applied to particle
sizing [8, 9, 10, 11, 12, 13, 14]. However, field of view ultimately limits the throughput of analysis
for any imaging technique applied to molecular or particle sizing.

Taylor dispersion analysis (TDA) is a powerful analytical method for size characterization
that addresses many of the shortcomings of the more common methods described above. Size
determinations by TDA are absolute, requiring no calibration nor prior knowledge of sample
concentration [15]. TDA conducted in fused silica capillaries requires only sub-nanoliter sample
volumes, and the method can be applied to sizing analytes from small molecules [16, 17, 18, 19, 20]
to micron-scale particles and complexes [21, 22]. TDA has evolved from studying gaseous
diffusion coefficients in large tubes [23, 24, 25] to TDA measurements of therapeutic proteins
[26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], drug delivery systems [26, 30, 37, 38, 39, 40, 41, 42],
nanoparticles [43, 44, 45, 46, 47, 48, 49, 50, 51, 52], mixtures [15, 44, 53, 54, 55, 56, 57, 58, 59],
synthetic polymers [30, 60, 61, 62, 63, 64], and more. While TDA has been discussed in other
reviews of physiochemical characterization methods in specific application areas[65, 66, 67, 68,
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69, 70], to our knowledge no recent review has combined a tutorial discussion of the underlying
principles and practical considerations of TDA with an outline of the breadth and depth of modern
TDA applications. Here, we offer a tutorial review of TDA, intended to make the method better
understood and more widely accessible to a community of analytical chemists and separations
scientists who may benefit from the unique advantages of this versatile sizing method.

3.3

Principles of TDA

First described by Taylor in 1953 [23], TDA enables the direct determination of diffusion
coefficients across a wide range of hydrodynamic radii (Å –µm).

TDA is a mathematical

framework for analyzing dispersion that results from the interaction between the parabolic velocity
profile of pressure driven laminar flow in a cylindrical tube and the radial diffusion of analytes
across that velocity profile. A sample plug injected into flow spreads axially due to the combined
effects of convection and diffusion, which is observed as band broadening (Fig. 3.1). Diffusion
occurs both radially and longitudinally, however TDA is conducted under well-controlled flow
conditions (discussed in more detail below) that ensure the contribution to band broadening from
longitudinal diffusion is negligible. As a result of the parabolic velocity profile, the initial velocity
of any individual analyte molecule or particle is a function of its starting radial position within
the injected sample plug. As radial diffusion proceeds, each molecule or particle samples the full
range of flow velocities in the parabolic profile over the duration of flow, resulting in an ensemble
average velocity across all particles in the sample population.

Analytes with low diffusion coefficients move slowly across the parabolic velocity profile such
that two analyte particles starting with disparate velocities remain separated within their respective
flow streams for a longer duration as compared to the behavior of analytes with higher diffusion
coefficients. The net result is a broad distribution of velocities about the population mean velocity
for analytes with low diffusion coefficients, which is observed as a high degree of band broadening.
Conversely, molecules with relatively high diffusion coefficients move rapidly across the parabolic
velocity profile, experiencing a narrower distribution of velocities about the population mean, thus
a lower degree of band broadening is observed.
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Figure 3.1: Illustration of Taylor dispersion, and the corresponding variables utilized in TDA.
Under the parabolic velocity profile of pressure-driven flow, and neglecting any effects of diffusion,
a sample plug would deform as illustrated (i). Considering the effects of diffusion only in the radial
direction gives Taylor dispersion, yielding the band profiles illustrated (ii). The evolution of Taylor
dispersion can be observed as band broadening of a peak measured at multiple locations in the flow
path (iii). The variables t1 , t2 , Rc , σ1 , and σ2 are the same variables utilized in Equation 3.13.
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It is worth noting here that the relationship between diffusion coefficient and band broadening
observed by TDA may seem counterintuitive to many separations scientists more accustomed to
considering longitudinal diffusion. By the mechanism of longitudinal diffusion, higher rates of
diffusion result in increased band broadening, which is the opposite of what is described above.
Nevertheless, when considering only radial diffusion in TDA measurements, molecular diffusion
coefficients (D) can be determined by observing the degree of band broadening as follows [71, 72]:

D=

Rc2 td
24σ 2

(3.1)

where Rc is the channel radius, td is the average elution time, and σ 2 is the peak variance. D can
be used as a structural descriptor of the analyte when transformed to RH via the Stokes-Einstein
relation [73]:

RH =

kB T
6πηD

(3.2)

where kB is the Boltzmann constant, T is temperature, and η is the dynamic viscosity of the
solution.

For TDA to yield accurate determinations of D, precise control of flow is required to meet two
requisite conditions known as the Taylor conditions. First, TDA considers radial diffusion while
neglecting longitudinal diffusion. For this to be possible, the rate of advection must be significantly
greater than the rate of diffusion, which is widely considered to be satisfied when the Peclet number
(P e) is greater than 69 [74]. P e is defined for a cylindrical channel as [72]:
Pe =

uRc
D

(3.3)

where u is the linear flow rate. In his original work [74], Taylor defined the following inequality
as a requirement to satisfy eqn (3.1):
4L
uRc
>>
>> 6.9
Rc
D
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(3.4)

where L is the length of the channel. In that work, a ratio of 1:10 between the inequalities
was considered requisite, which gives the accepted Taylor condition P e ≥ 69. Cottet et al.
demonstrated that longitudinal diffusion can be neglected even in conditions where P e < 69,
defining requisite flow velocity as [56]:
D
u≥
Rc

r
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(3.5)

where  is the relative error in determination of D. By this analysis, Taylor’s condition of P e ≥ 69
gives a relative error due to neglecting longitudinal diffusion of 1%, whereas Cottet and coworkers
suggest that a relative error of 3% can be tolerated, leading to the requisite condition P e ≥ 40.

The second Taylor condition describes the duration for which a sample plug must remain in
flow in order to observe sufficient band-broadening effects due to Taylor dispersion. Taylor’s
original work described the condition as follows: “the time necessary for appreciable effects to
appear, owing to convective transport [must be] long compared with the ‘time of decay’ during
which radial variations of concentration are reduced to a fraction of their initial value through the
action of molecular diffusion” [23]. As such, the requisite residence time (tR ) of the sample plug
in flow is influenced by D and Rc . Residence time can be normalized for these factors to give a
dimensionless time factor (τ ) defined as:

τ=

DtR
Rc2

(3.6)

Taylor expresses eqn (3.6) as the inequality[74]
Rc2
D >>
4tR

(3.7)

Taking a 1:10 ratio as satisfying Inequality (3.7), the following condition satisfies minimum
required

tR ≥ 2.5

Rc2
D

(3.8)

Substituting tR in eqn (3.6) with Inequality (3.8), we can obtain the minimum required value for τ :
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2

D(2.5 RDc )
DtR
τ= 2 =
≥ 2.5
Rc
Rc2

(3.9)

Alternative minimum τ values have also been reported. In the same work that studied alternative
minimum P e conditions, Cottet et al. demonstrate that the minimum tR can also be expressed as
a function of  as follows[56]

tR ≥

3Rc2
80D

(3.10)

Presuming an acceptable  of 3%, Inequality 3.10 becomes:

tR ≥

1.25Rc2
D

(3.11)

Substituting tR in eqn (3.6) with Inequality (3.11), we can obtain the minimum required value for
τ:
2

D(1.25 RDc )
DtR
τ= 2 =
≥ 1.25
Rc
Rc2

(3.12)

There is some disagreement on appropriate limiting value of τ . Several works report the condition
τ > 1.4 [45, 72, 75, 76]. However, to our knowledge, no mathematical basis for alternate limiting
τ values has been offered with the rigor of either Taylor or Cottet’s solutions shown above.

3.4

Practical Considerations for TDA Measurements

Several practical considerations arise from the requisite Taylor conditions. First, eqn (3.6) shows
that analysis times can be dramatically reduced by reducing Rc . This has motivated the use of
fused silica capillaries (typ. 10 - 250 µm i.d.) as flow systems for TDA. As a result, capillary
electrophoresis (CE) instrumentation has become a prominent tool in the continued development
and application of TDA. Second, although TDA is a method for determining D, target values of
D are needed to define the requisite Taylor conditions. Since the Taylor conditions are met by
exceeding thresholds (i.e. τ ≥ 2.5 and P e ≥ 69), a priori knowledge of D is not required. Instead,
careful consideration is needed to bracket an appropriate range of D values for a given analysis,
which can be used to deduce the limiting values of operating parameters u, Rc , and tR that satisfy
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the Taylor conditions. Finally, it is impractical to consider the two requisite Taylor conditions
independently when designing the parameters of a TDA experiment. For example, P e must exceed
a value of 69 but is given no theoretical upper bound, which suggests there is no upper bound of
the operating parameter u and therefore flow velocity should be maximized. While u is not given
an upper bound on the basis of theory, increasing u requires increasing capillary length in order
to achieve a value for tR to satisfy τ > 2.5, and impractical capillary lengths can quickly arise
from poorly chosen u values. Thus, practical limitations require a careful selection of operating
parameters to meet the Taylor conditions for an appropriately bracketed range of D. With careful
consideration, and several iterative calculations of eqn (3.3) and eqn (3.6), selecting appropriate
and practical operating conditions for TDA is not prohibitively laborious. Still, making available
purpose-built calculation tools for establishing appropriate operating parameters would benefit
researchers currently utilizing TDA and may foster more widespread adoption of the technique.

Practical and theoretical limitations exist beyond the scope of appropriately selecting operating
parameters to meet the requisite Taylor conditions. For example, the TDA principles described
above assume that the sample plug remains under continuous flow for the full duration of
tR . In practice, this can be difficult or impossible to achieve, especially when utilizing CE
instrumentation. The act of injecting a sample plug via conventional CE injection methods
necessarily gives discontinuous flow velocities because flow must be stopped to bring a sample
vial to the capillary inlet and stopped again to return a buffer vial to the capillary inlet before flow
recommences for the TDA procedure. A key to overcoming this limitation has been the use of dualdetector schemes [16, 17, 77, 78], in which band broadening is compared between two detection
points positioned on the flow path to achieve the appropriate tR value within the volume between
the detection points. In this way, band broadening evolves while under continuous flow between
the two detection points, and any contribution to overall band broadening from discontinuous flow
in the sample injection process is accounted for in the initial observation at the first detection point.
Dual-detector TDA utilizes a modified form of the Taylor-Aris equation as follows [76]:

D=

Rc2 (t2 − t1 )
24(σ22 − σ12 )
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(3.13)

where t1 and t2 are the peak arrival times at detectors 1 and 2, respectively, and σ12 and σ22 are the
peak variances as observed at detectors 1 and 2, respectively.

Chamieh et al. compared the performance of TDA in single- and dual-point detection
configurations [53]. In their work, TDA of monodisperse albumin proteins and polydisperse
polymer standard samples was performed utilizing a commercial CE instrument equipped with a
60 cm x 50 µm i.d. fused silica capillary and UV absorbance detector. For single-point detection,
band broadening was analyzed for signals collected at three detector positions (effective capillary
lengths: 8.5 cm, 24.5 cm, and 51.5 cm). For dual-point detection, signals were analyzed with
detection points positioned at 24.5 cm and 51.5 cm. Unsurprisingly, single-point detection TDA
resulted in overestimates of RH when the injection volume was a significant fraction (> 1%) of
the total effective capillary volume. Utilizing previously reported mathematical corrections[17]
for the effects of pressure ramping and the finite volume of the injection plug, RH determinations
by single-point detection TDA were not statistically different from those determined by dual-point
detection, provided injection volume remained < 1% of effective capillary volume. However, dualpoint detection TDA is arguably preferable, as it does not require any mathematical corrections or
presumptions of dynamic flow conditions which may be difficult to observe. To facilitate precision
TDA, technologies have been developed to achieve dual-detector configurations in commercial CE
instrumentation for UV absorbance[17] and fluorescence detection[16] modes.

TDA analysis times are significantly reduced by decreasing Rc , which has motivated the use
of fused silica capillaries. Precise control of applied pressures to a capillary flow system can be
achieved with modern commercial CE instrumentation, making these instruments well suited for
TDA. Williams and Vigh leveraged the integration of CE and TDA in a commercial instrument
by first separating analytes by CE then switching to pressure driven flow to perform TDA on
the separated analytes [79]. One critical challenge in using a commercial CE instrument was
described by Sharma et al., who described the effects of the initial ramp in flow velocity that occurs
upon pressure application [72]. This non-uniform velocity profile introduces significant error in
determinations of D. To circumvent this effect, ramp rate can be characterized and corrected for
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mathematically. The ramp rate of the CE instrument must be determined and used to convert the
observed residence time to the ideal residence time by the equation:
tR,obs +
tR =

q

t2R,obs − 16LT LD η/Rc2 ri
2

(3.14)

where LT is capillary length, LD is tube length from inlet to detector, and ri is the rate of increase
of applied pressure. When there is no initial velocity ramp, tR = tR,obs and D can be determined
simply by eqn (3.1). However, a velocity ramp leads to errors in the measured values of D if
not corrected using eqn (3.14). With increased tR,obs the effect of ri becomes negligible, and as
tR,obs approaches infinity, any error in D would approach zero. Thus, the effect of the ramp is
greater at lower tR,obs . To demonstrate this, the error in D determinations for phenylalanine was
characterized as a function of tR,obs . Errors greater than 50% were observed for tR,obs < 50s
whereas < 1% error was observed for tR,obs > 100s. Correcting for flow velocity ramp by eqn
(3.14), reduced the error at all tR,obs evaluated to < 2%. While this correction was straightforward
for frontal analysis, zonal analysis required additional corrections to account for the finite width
of the injection plug. The additional correction required the calibration of observed peak variance
2
(σobs
) vs injection volume (Vi ) at each tR . Thus, correcting for a velocity ramp in zonal analysis

can add substantial additional work to the overall workflow.

The operating principles of TDA are conceptually similar to those of hydrodynamic chromatography (HDC), although these are mechanistically distinct modes of analysis. Cottet and
coworkers characterized the relationship between RH , applied pressure, and capillary diameter to
elucidate the conditions under which HDC mechanisms interfere with the accurate interpretation
of TDA results [80]. In Figs. 3.2A and 3.2B, the red lines correspond to experimental conditions
of constant analyte size (vertical line) or constant mobilizing pressure (horizontal lines), and
the dots represent the conditions illustrated in Figs. 3.2C and 3.2D. When 250 nm polystyrene
nanoparticles (PS NPs) were analyzed by TDA utilizing a 50 µm i.d. fused silica capillary under
mobilization pressures from 7 – 550 mbar, peak shape became distorted at and above 90 mbar
(Fig. 3.2C). Interestingly, the conditions with observed peak distortion corresponded to τ ≤ 1.25,
which fails to satisfy the requisite Taylor condition. When various sizes of PS NPs (RH = 110
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nm, 250 nm, 500 nm) were analyzed by TDA utilizing 25 µm i.d. fused silica capillary and a
fixed mobilizing pressure of 28 mbar, the effects of HDC reduced elution times of 250 nm and
500 nm PS NPs (Fig. 3.2D). Importantly, HDC affected the variance of the NP peaks even without
appreciable effects on mean elution time, which adversely affected the accuracy in determinations
of D. The authors identified an upper limit on the ratio of RH to capillary radius (RC ) as a function
of  given by:
RH
= 0.17
Rc

(3.15)

In many cases, especially when designing TDA experiments for the analysis of macromolecular
constructs, this constraint will warrant careful consideration when selecting appropriate operating
parameters to meet the Taylor conditions.

Another important consideration is the potential for analyte-capillary adsorption, which will
introduce peak asymmetry in the resulting elution profile, or taylorgram. Latunde-Dada et al.
observed asymmetric peaks with pronounced tailing in varying concentrations of lysozyme (1 - 20
mg mL−1 ) in a standard 75 µm i.d. capillary [81]. As an attempt to mitigate the effect of peak
tailing on RH determinations, they developed a constrained fitting algorithm to isolate dispersive
components of the concentration profiles from the solute-capillary interacting components. This
mathematical correction yielded improved accuracy in RH determinations for high concentration
(i.e. 5 - 20 mg mL−1 ) lysozyme samples. Interestingly, at 1 mg mL−1 lysozyme, both free and
constrained fits gave inaccurate RH determinations (4.5 ± 0.3 nm and 3.33 ± 0.03 nm, for free
and constrained fits, respectively as compared to previously reported values of 1.89 - 2.05 nm
[82, 83]). The authors postulated that these inaccuracies resulted from a much greater fraction of
total sample engaged in adsorptive interactions at the capillary wall and, thus, subject to a net flow
velocity that did not meet the Taylor criteria. Here, we suggest that adverse adsorption effects
may warrant adapting common practices from CE methods, such as capillary surface modification
or buffer additives [61, 84, 85], for use in TDA measurements. Such efforts will require careful
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Figure 3.2: Illustration of the conditions under which HDC mechanisms interfere with the accurate
interpretation of TDA results for A) 50 µm i.d. and B) 25 µm i.d. capillaries. Red lines correspond
to experimental conditions of constant analyte size (vertical) or constant mobilizing pressure
(horizontal lines), and the dots represent experimental conditions investigated. Taylorgrams
obtained from PS NPs with C) constant analyte size at various mobilizing pressures and D) constant
mobilizing pressure with various analyte sizes. Note that deviations from gaussian peak shape
arise when experimental conditions enter the HDC regime, illustrated as shaded green region in
A and B. Adapted with permission from: Chamieh J, Leclercq L, Martin M, Slaoui S, Jensen H,
Ostergaard J, et al. Limits in Size of Taylor Dispersion Analysis: Representation of the Different
Hydrodynamic Regimes and Application to the Size-Characterization of Cubosomes. Anal Chem.
2017; 89(24):13487-93. Copyright (2017) American Chemical Society.
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consideration and characterization of the effects on solution viscosity to yield accurate calibrationfree size determinations.

Though the principles of TDA were first described in the early 1950s, modern capillary flow
systems have enabled this technology to be leveraged more recently as a powerful technique
for size determination in various application areas and across various modes of analysis. For
example, in addition to UV absorbance [17] and fluorescence detection [16, 86] modes, TDA has
been coupled to mass spectrometry [87, 88], refractive index detection [62], and backscattering
interferometry [89]. To this point, we have considered TDA of pure substances. TDA leverages
tools common to separation science, and therefore it is interesting to examine how the practice and
principles of TDA become more complex in the context of sample mixtures.

3.5

Algorithmic Approaches to TDA of Mixtures

TDA is applicable to both monodisperse and polydisperse samples [53, 55]. For monodisperse
samples, TDA results for the determination of RH are directly analogous to those of DLS, which
is a standard method for particle size characterization [55]. Conventionally, TDA gives weightaveraged or number averaged RH values when utilizing mass- or concentration-sensitive detection
modes, respectively [15]. Thus, the resulting RH determinations for polydisperse samples can
differ from the harmonic z-averaged RH value obtained by DLS [90]. This incongruency with DLS
has motivated various regression and statistical analysis approaches to improve the performance of
TDA for mixtures and polydisperse samples.

Common peak fitting methods for non-Gaussian peak shapes have been applied to TDA data
for the analysis of polydisperse samples. Deviations from a strict Gaussian peak shape were
observed at the apex and base of taylorgrams produced from a mixture of third and fifth generation
dendrigraft poly-L-lysine, complicating the determination of appropriate peak variance in the
taylorgram [53]. In the case where Gaussian fits cannot be applied to taylorgrams of polydisperse
samples, peak variance can be determined via an integration-based algorithm. In that work, peak
variance was determined by integrating the whole signal of the resulting non-gaussian peaks across
the time interval using the following equation:
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R
2

σ =

h(t)(t − td )2 dt
R
=
h(t)dt

Pi=n
2
m hi (ti − td ) (ti+1 − ti )
Pi=n
m hi (ti+1 − ti )

(3.16)

where h(t) is detector response, ti is elution time for a given point i, td is the average elution time,
n and m are the starting and ending points considered for the integration. This integration method
yielded a weight-average RH determination. Furthermore, this method depended heavily on the
selection of the boundaries for integration, defined by the variables n and m. Several boundaries
were considered defined by cutoff lines ranging from 0 - 2% of the peak apex (Fig. 3.3A). Fig. 3.3B
compares the results of the integration method (data points) with the results of conventional
gaussian fitting (horizontal dashed lines). A general trend of reduced mean RH with increased
cutoff percentage was observed. Comparison of the mean RH values obtained from the integral and
gaussian fitting methods revealed no significant difference and agreement with 95% confidence.
However, for third and fifth generation dendrigraft poly-L-lysine (G3 and G5), poor agreement
was observed between the Gaussian fitting and integration methods at all cutoff percentages. The
authors attributed this to Gaussian fitting being poorly suited for the irregular peak shapes of
G3 and G5. To prevent contributions from noise influencing the integration method, the cutoff
line corresponding to 4 x σnoise was defined as the appropriate threshold, which in this work
corresponded to 0.75% of the peak apex (Fig. 3.3B, vertical dashed line).

Data analysis methods have been developed to extract multiple constituent RH values from the
taylorgrams of mixtures [15, 55, 56]. In one example, three independent data analysis methods
were applied to monitoring a polymerization reaction by TDA [55]. In the first method, the degree
of conversion was determined by comparing integrated areas in the taylorgrams before and after the
polymerization reaction. In the second method, the taylorgrams for each component in the reaction
mixtures were recorded and fitted as Gaussian curves, and the taylorgram for the reaction mixture
was deconvolved by fitting as the sum of Gaussian curves for the mixture components. The third
method subtracted the Gaussian contribution of the monomer mixture from the taylorgram of the
reaction mixture and fitted the reduced signal iteratively to extract the polymer contribution. Three
standards of polyacrylamide (PAM) with varying weight average molar masses and acrylamide
(AM) monomer were analyzed by TDA individually and as AM/PAM (10:90 v:v) mixtures for
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Figure 3.3: Graphical representation of variance determination by peak integration. A) Integration
boundaries are represented by cut-off lines given as percentage of the peak apex (horizontal
dashed lines); and B) resulting trends in RH measurements as a function of integration cuttoff boundaries. The limiting cutt-off boundary was determined to be 0.75% (vertical dashed
line), which represented 4 x σnoise . RH measurements by the integration method (data points)
are compared to standard gaussian peak fitting values (horizontal dashed lines). Reprinted
from Journal of Chromatography A, Vol. 1241, Joseph Chamieh, Herve Cottet, Comparison of
single and double detection points Taylor Dispersion Analysis for monodisperse and polydisperse
samples, 123-127, Copyright (2012), with permission from Elsevier.
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each molar mass standard to mimic a polymerization medium. Peak profiles in AM/PAM mixtures
were shown to be the sum of the contributions from each component, as illustrated in Fig. 3.4A.
All three data analysis methods determined RH = 0.22 nm for AM, while RH values for AM/PAM
agreed across all methods to within 0.5 nm. TDA was performed on aliquots of an acrylamide
polymerization reaction mixture at several time points, as illustrated in Fig. 3.4B. The three
methods were separately utilized to determine RH for the resulting PAM, and all methods agreed
to within 4%.

Cipelletti described a cumulant analysis method for determining the polydispersity of moderately complex sample mixtures [54]. By the cumulant method, the logarithm of any taylorgram can
be expanded into a cumulant series, in which the first cumulant (Γ1 ) is directly related to the mean
of the gamma distribution of D. The authors showed that polydispersity could be characterized by
evaluating the deviation from linearity in the plot of the cumulant series. In further work, Cipelletti
etal. described the constrained regularized linear inversion (CRLI) approach for determining
probability density functions (PDFs) of D from taylorgrams [44]. This added additional constraints
to the standard least-squares fit to overcome the difficulties of an infinite set of PDF solutions that
fit the taylorgram function. D averages were determined by CRLI approach that agreed to within
10% of the expected values utilizing both simulated and experimental data, and up to 10% error
was observed for determinations of polydispersity indices of various polystyrenesulfonate samples
and mixtures.

Latunde-Dada et al. described an algorithmic approach to deconvolution of taylorgrams of
mixtures based on initial parameter estimations as seed values for fitting by least squares regression
[57]. In that approach, a system of equations describing the relative contributions of various peak
amplitudes and variances can be solved using initial parameters derived from the second derivative,
integral, and double integral of the net taylorgram signal. The authors demonstrated the utility of
their approach in various use cases, including 2, 3, and 4 component mixtures of related and
unrelated analytes, and with various conditions of a priori knowledge of analyte radius. In each
case, hydrodynamic radii in good agreement with nominal reported values were determined for all
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Figure 3.4: A) Taylorgram of an AM/PAM standard mixture with UV absorbance detection (solid
line). The signal was deconvoluted by fitting to the sum of two gaussian curves (dashed lines)
. B) TDA time course profile of acrylamide polymerization with UV absorbance detection at
191 nm. Signal analysis using three methods based on conservation of mass of sample injection,
deconvolution via gaussian fits, and deconvolution via monomer contribution subtraction results
in RH determinations that agree to within 4%. Adapted with permission from: Cottet H, Biron
JP, Cipelletti L, Matmour R, Martin M. Determination of Individual Diffusion Coefficients in
Evolving Binary Mixtures by Taylor Dispersion Analysis: Application to the Monitoring of
Polymer Reaction. Anal Chem. 2010; 82(5):1793-802. Copyright (2010) American Chemical
Society.
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mixture components.

These examples illustrate that fitting and deconvolution algorithms can be applied to interpreting taylorgrams of sample mixtures. Although no theoretical upper limit has been proposed
for the number of mixture components that can be handled by these methods, the mathematical
complexity and uncertainty inherent to such approaches suggests that they are best reserved for
relatively simple mixtures. Applications requiring increased resolution and peak capacity will
benefit from the common instrumentation shared by both CE and TDA, which facilitates their
online integration.

3.6

Integrating CE and TDA

As we previously discussed, dual-point detection is an effective approach to circumventing
challenges of non-uniform or discontinuous flow velocities in TDA, but it presents an engineering
challenge of integrating two detection points within the confines of commercial CE instrumentation. Chamieh et al. implemented a dual-point UV detection approach by looping the capillary
inside of a standard CE capillary cassette such that it passed the UV detection point twice before
exiting the cassette (Fig. 3.5A) [17]. This required modification of the instrument’s detection
interface to allow both detection windows on the looped capillary to overlap within the same
interface. Fig. 3.5B (top) compares the taylorgrams obtained for 75 µM HSA using the unmodified
interface (gray trace) and the modified interface (black trace). A 10-fold decrease in sensitivity was
observed when using the modified detection interface, which the authors attributed to the removal
of a spatial filtering slit which typically prevents transmission through the capillary in regions
outside of the capillary inner diameter. However, reduced sensitivity did not adversely affect the
observed peak variance or elution profiles of sufficiently concentrated samples, as observed by the
normalized data in Fig. 3.5B (bottom). Dual-point UV detection was utilized to determine RH at
two mobilizing pressures (30 and 50 mbar, respectively) for 10 mM caffeine (RH = 0.462 ± 0.013
nm and 0.436 ± 0.017 nm), 75 µM BSA (RH = 4.10 ± 0.12 nm and 4.13 ± 0.13 nm), and 75
µM HSA (RH = 4.19 ± 0.09 nm and 4.25 ± 0.14 nm) and in all cases were found to agree with
literature values to within 5%.
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Figure 3.5: A) Illustration of a looped capillary within a standard CE instrument cassette for
double detection TDA with UV absorbance detection. B) Raw data (top) and normalized data
(bottom) taylorgrams of HSA by conventional single-point UV absorbance detection interface
(gray trace) and modified double detection interface (black trace). Note a dramatic reduction
in sensitivity (ca. 10-fold) for the modified double detection interface. Normalized data shows
no substantial difference in peak variance or elution time between detection methods. Adapted
from Journal of Chromatography A, Vol. 1235, Joseph Chamieh, Farid Oukacine, Herve Cottet,
Taylor dispersion analysis with two detection points on a commercial capillary electrophoresis
apparatus, 174-177, Copyright (2012), with permission from Elsevier. C) Schematic illustration
and photograph (scale bar is 5 mm) of a miniature 3D printed fluorescence detector for two-point
fluorescence detection in a commercial CE instrument. D) Raw (top) and Gaussian fitted (bottom)
data from CE-TDA of FITC-BSA conjugation reaction. TDA determinations of RH enabled peak
assignments of FITC-BSA (first peak) and free FITC (second peak). Adapted with permission
from: Casto LD, Do KB, Baker CA. A Miniature 3D Printed LED-Induced Fluorescence Detector
for Capillary Electrophoresis and Dual-Detector Taylor Dispersion Analysis. Anal Chem. 2019;
91(15):9451-7. Copyright (2019) American Chemical Society.
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Fluorescence is often utilized as a detection mode in CE because it overcomes pathlength
limitations of UV-absorbance detection in small diameter capillaries, but the integration of
dual-point fluorescence detection in commercial CE instrumentation is challenging. Our group
developed a miniature LED-induced fluorescence detection system for CE that was sufficiently
compact to enable the integration of two detectors within the cassette of a commercial CE
instrument [16]. The 3D printed design, shown in Fig. 3.5C incorporated an LED excitation
source, bandpass excitation filter, pinhole collimator, and emission-collecting ball lens. Operating
conditions such as LED current, and PMT gain control voltage were optimized via multivariate
analysis to yield a detection limit of 613 ± 13 pM for fluorescein. The system was used to
monitor the progress of a fluorescent bioconjugation reaction between fluorescein isothiocyanate
(FITC) and BSA, and the integration of CE-TDA with fluorescence detection was shown to enable
standard-free identification of peaks in the CE separation. Fig. 3.5D shows the overlay of signals
obtained from both detectors (solid and dashed black traces) and the corresponding Gaussian fits
(solid and dashed red traces) at reaction time = 2 min. TDA of the CE-separated zones provided
RH values of 4.4 nm and 0.54 nm for peak 1 and peak 2, respectively, allowing the assignment of
these peaks to FITC-BSA and free FITC, respectively.

CE and TDA have been used together to monitor reaction progress in other systems. Affinity
CE is widely utilized for studying biomolecular interactions, and in this regard CE-TDA can offer
advantages for elucidating biophysical and functional properties of binding systems. Østergaard
and Jensen demonstrated the first application of CE-TDA for the simultaneous characterization of
protein-ligand binding and protein RH in two separate affinity systems [76]. Advancing fronts
were used to obtain D and RH values for free ligands, α1 -acid glycoprotein (AGP) and human
serum albumin (HSA), and for propranolol-ligand complexes to investigate and quantify their
interactions. Differences in the degree of binding between propranolol-AGP and propranolol-HSA
were significantly different, showing a trend in agreement with previous literature. Further, Liu
et al. monitored surface functionalization of dendrigraft poly-L-lysines (DGL) [91]. TDA was
used to determine the RH of the polypeptides and of a click reaction product. While the results
confirmed the reaction, TDA gives a weight average RH which does not provide information on
reagent or product purity nor homogeneity. CE was used separately from, and complimentary to,
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TDA to characterize the reaction mixture components. Comparison of electropherograms of the
clicked product spiked with the starting materials and intermediate compounds clearly illustrated
the absence of these reaction components in the final product. Similarly, Deschamps et al.
characterized the size of an ionic polydiacetylene by TDA while monitoring its polymerization
process by CE [92]. RH values for the polymer were reported as 1.77 nm and 1.9 nm by TDA and
DLS, respectively, where the small difference was attributed to sample polydispersity. CE results
were used in this study to determine degree of polymerization, polydispersity index, and number
average molar mass. CE is also well-suited for online integration with TDA, which combines in a
single analysis the high resolving power of CE with RH determinations by TDA [93]. A mixture
can be electrophoretically separated with high resolution while experimental traces from the same
detector are recorded and used for TDA. Several groups have reported success in on-line integration
of CE-TDA for monitoring of bioconjugation reactions [16, 76], nanoparticle characterization
[49, 50, 78, 94], characterization of charged complexes [93, 95], and more.

Characterizing the 3D structure of proteins and biomolecules is critical in understanding their
biological function. Xu and coworkers developed mobility capillary electrophoresis (MCE) to
circumvent challenges associated with common structural analysis techniques [96, 97]. MCE
combines CE with suppressed electroosmotic flow and TDA to enable determinations of RH and
effective ionic charge from a single experiment. MCE has been demonstrated in combination with
mass spectrometry and molecular dynamics simulations for 3D protein structural analysis from
solution-phase samples. MCE has been applied to a variety of proteins and protein mixtures, under
native conditions and non-native pH conditions [98, 99].

The characterization of size and function in non-biological systems by CE-TDA has also been
reported. Leclercq and Cottet proposed a methodology for the characterization of polyelectrolyte
complexes in which a CE separation of constituents followed by TDA allows for the determination of charge stoichiometry and RH , respectively [95]. Oukacine et al. utilized the high
separation performance of CE in conjunction with the absolute size determination of TDA for
the determination of RH of a bimodal mixture of nanolatexes (56 and 70 nm in size) [78]. First,
a baseline separation of the two nanolatexes by CE was required before TDA could be performed.
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A UV detector and capillary with three detection windows in a looped configuration was used in
this study. Reported values of D were in good agreement with values obtained by TDA of the
two nanolatexes individually, ultimately demonstrating CE-TDA as a suitable approach for the
characterization of mixtures of nanoparticles similar in size.

3.7

Applications of TDA to Bioanalysis

Analysis of biological and pharmaceutical compounds can take advantage of the low sample
volumes of TDA, since sample availability in these cases can be limiting [54]. Such compounds
include therapeutic peptides and proteins [26, 27, 28, 29, 31, 32, 33, 34, 35], drug delivery systems
[30, 37, 38], and lipids [39, 40, 41, 42]. Diffusion and transport through tissue mimics, hydrogels,
and capillaries has also been modeled for biological applications [30, 31, 100].

Hulse et al. demonstrated TDA for the size characterization of therapeutic proteins and their
respective aggregates [28]. 60 nL of 10 mg mL−1 bovine serum albumin (BSA) were prepared
and analyzed in less than 3 minutes using a commercial TDA instrument. RH was determined to
be 4.18 nm with an RSD of 0.24%, which was in agreement with previously reported values of 3.3
- 4.3 nm. Aggregation was induced in two samples of BSA via heat stress. Comparing average
RH values of BSA determined by DLS and TDA, it was determined that greater repeatability
was achieved with TDA, indicated by < 1% RSD as compared to 7.09% RSD by DLS in each
aggregated sample.

Høgstedt et al. assessed protein-protein and peptide-peptide interactions (PPIs) by TDA [27].
PPIs can be characterized by the diffusion interaction parameter, kD , which is observed as the
slope of the linear fit in a plot of D vs analyte concentration. A comparison of TDA and DLS for
characterizing PPIs in model peptides was not possible since, the authors reported, DLS lacked
appropriate detection sensitivity for the model peptides. Therefore, TDA and DLS were compared
for characterizing PPIs for the proteins α-lactalbumin and HSA with highly comparable results.
The higher sensitivity of TDA enabled observation of repulsive and attractive PPIs in a set of three
model peptides. Furthermore, Latunde-Dada et al. proposed a method for obtaining concentration
dependent diffusion coefficients and kD in a single measurement by measuring dispersion as a
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function of concentration along the front of a sample slug [18]. For the application to caffeine and
BSA solutions, the values and signs of kD as well as the values of D were in good agreement with
literature values and DLS results.

Protein-ligand interactions have also been studied by TDA coupled to mass spectrometry
(TDA-MS). Hong et al. investigated noncovalent interactions of lysozyme and cytochrome C with
tri-N-acetylchitotriose [87]. A home-built sample introduction system utilizing branched capillary
channels and constant pressure pumping enabled two-point detection TDA-MS via electrospray
ionization. Peaks corresponding to the protein, ligand, and the protein-ligand complex were well
resolved by MS, and effective charges were determined. Ion chromatograms from the mass spectra
were used for RH determinations by TDA. TDA results showed a 6.963% and 7.53% increase in
RH of lysozyme and cytochrome C, respectively, after incubation with the ligand, indicative of
protein-ligand binding.

Nanoscale hydrogels are utilized as drug delivery systems, enabling spatial, temporal, and
stimulus-controlled drug release. Size characterization of these nanogel delivery systems is
important, since size distribution influences in vivo diffusion, biodistribution, and ultimately the
biological fate of these drug delivery vehicles [30]. Several studies have been successful in
characterizing these drug delivery systems via TDA. Ibrahim et al. have worked to characterize
the size and effective charge of a polymeric nanogel by TDA and CE, respectively [30]. Four
copolymer nanogels were sized by TDA, resulting in an RSD of < 2.2% for all RH values,
while effective ionic charge (zef f ) was determined for each nanogel from electrophoretic mobility
and RH . Jensen et al. have also studied hydrogel matrices as drug delivery systems, but as a
subcutaneous tissue mimic [31]. A UV imaging method was combined with TDA to visualize and
characterize diffusivity and self-association behavior of insulin within an agarose hydrogel matrix
in real-time. At various concentrations, insulin monomers and hexamers were easily distinguished
by TDA. Low concentrations (0.1 and 0.2 mM) and pH (3.0) resulted in RH = 1.5 ± 0.1 nm,
representing the monomeric form of insulin, and high concentrations (1 mM) and moderate pH
(7.4) resulted in RH = 3.0 ± 0.1 nm, indicative of the insulin hexamer. The authors reported that
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DLS was less sensitive to these small changes in hydrodynamic radius.

Ye et al. demonstrated the application of TDA to characterizing D and RH values of drug
substances in water and various pharmaceutical media (acetonitrile, methanol, isopropyl myristate,
medium chain triglyceride, and propylene glycol), along with simultaneous measurements of
solvent viscosity [37]. Relative solvent viscosity measurements were made using the two detection
windows and water as a reference viscosity standard by the following equation:
η=

ηwater (t2,s − t1,s )
t2,water − t1,water

(3.17)

where η is the relative solvent viscosity, ηwater is water viscosity, t1,s and t2,s are the times at
which the analyte in the solvent reaches detection windows 1 and 2, respectively, and t1,water and
t2,water are the times at which the analyte in water reaches detection windows 1 and 2, respectively.
Viscosity was determined for all solvents with RSD < 1%. This work highlights the importance
of considering solvent viscosity in RH determinations, since D significantly decreases with
increasing solvent viscosity, which can lead to overestimation of RH . Simultaneous determination
of solvent viscosity and D by TDA offers a promising approach to circumventing this problem.

Surfactant micelles or microemulsions are used as drug delivery systems to improve the
solubility and bioavailability of drugs with poor water solubility. Formulations of these lipid-based
excipients can be complex and, as with other drug delivery systems, their size characteristics will
impact the efficacy of the drug delivery system. Chamieh et al. have made significant contributions
to the characterization of micelles and microemulsions by TDA. TDA is well suited to this purpose
because it is less sensitive than DLS to deleterious effects from aggregates, and variation in
viscosity of micellar solutions can readily be accounted for. The effect of concentration and
temperature on the size of commercial self-emulsifying pharmaceutical excipients was investigated
by TDA and results compared to DLS measurements. The two excipients studied, Labrasol® [40]
and Gelucire® 44/14[39], were found to have opposite trends in behavior based on concentration
and temperature; Labrasol® microemulsions showed a decrease in the measured RH (90 nm to
6 nm) with increased concentration, while Gelucire® 44/14 showed an increase in measured RH
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(1 nm to 5.5 nm) with increased concentration. The authors postulate that this opposite trend
was due to coacervation in low concentrations of Labrasol® and increase in viscosity of higher
concentrations of Gelucire® 44/14.

An often-important criteria for drug delivery systems is the ability to keep the loaded drug
inside the prepared emulsion or droplet solution in the gastrointestinal tract, where digestive
enzymes are present. In continuation of their previous studies, Chamieh et al. monitored the
size of excipients during in vitro lipolysis under conditions simulating the gastrointestinal tract
[41]. Digestion of the excipients were monitored by TDA at several time points in the degradation
process. Similar to their previous work, an opposite behavior was observed, as Labrasol® droplets
decrease in size (Figs. 3.6A and 3.6B), due to the disappearance of coacervates that are unable
to solubilize the hydrophobic fluorescent marker and Gelucire® droplets increase in size during
lipolysis (Figs. 3.6C and 3.6D) due to the increase in micelle size, maintaining solubilizing
capacity. TDA was shown to be effective for size analysis of microemulsions and their behavior
under digestive conditions. TDA is also an effective method for quantifying peptide drugs released
from lipidic self-emulsifying drug delivery systems. The role of electrolyte ionic strength on the
release of two therapeutic peptides, leuprorelin and desmopressin has also been characterized [26].

3.8

TDA Applications in Nanomaterials Characterization

Physiochemical properties of inorganic nanoparticles (NPs) are primarily dependent on their size,
and TDA has proven well-suited for characterizing NPs. Sizing of NPs by TDA has been wellstudied and has demonstrated utility [43, 44, 45, 46, 47, 48, 49, 50, 51]. NP size characterization
by TDA has been compared to TEM imaging techniques and found to result in comparable particle
size values. For example, Balog et al. studied superparamagnetic iron oxide NPs (SPIONs), gold
(Au) NPs, and silica (SiO2 ) NPs and compared TDA to TEM in determination of particle radius
[43]. The reported radii of SPIONs, Au NPs, and SiO2 NPs were 7.6 nm, 33.8 nm, and 44.0 nm,
respectively, by TDA, and 6.7 ± 1.1 nm, 28.0 ± 4.7 nm, and 39.3 ± 6.2 nm, respectively, by TEM.

Sizing is also useful in characterizing the modification of NPs with adsorbed functional
components such as enzymes. Høldrich et al. investigated pepsin coated gold nanoparticles by
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Figure 3.6: Graphical comparison of diffusion coefficients and hydrodynamic radii of Labrasol®
and Gelucire® droplets during lipolysis at 37ºC. A) D measurements of Labrasol® droplets are
shown to increase and B) corresponding RH values decrease exponentially before reaching a
plateau. C) D measurements of Gelucire® droplets are shown to decrease and D) corresponding
RH values increase sigmoidally. Adapted from International Journal of Pharmaceutics, Vol. 537,
Joseph Chamieh, Habib Merdassi, Jean-Christophe Rossi, Vincent Jannin, Frederic Demarne,
Herve Cottet, Size characterization of lipid-based self-emulsifying pharmaceutical excipients
during lipolysis using Taylor dispersion analysis with fluorescence detection, 94-101, Copyright
(2018), with permission from Elsevier.
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DLS and TDA [47]. Pepsin was adsorbed onto synthesized gold nanoparticles (GNPs), with a DLS
measured diameter of 44.1 ± 0.3 nm, at varying concentrations to obtain a range of thicknesses
of the adsorbed layer. The average hydrodynamic diameter of pepsin-coated GNPs by DLS was
reported as 64 ± 2 nm, where the GNPs synthesized with different concentrations of the pepsin
coating solution were not significantly different. This suggests that DLS was unable to successfully
distinguish the small differences in hydrodynamic diameter of the pepsin-GNP bioconjugates as
compared to bare GNPs (Fig. 3.7A), while TDA successfully resolved increases in RH due to
pepsin adsorption as small as < 2 nm with a high degree of repeatability and accuracy (Fig. 3.7B).

Size characterization is also important for understanding organic materials, for observing
polymer synthesis and degradation, ligand binding, and monitoring reaction progress. The utility
of UV and fluorescence detection modes for TDA are discussed previously in this review. In
many situations pertinent to organic synthesis, however, molecules may exhibit neither significant
UV absorption nor fluorescence. Refractive index (RI) detection is a potential alternative in
these cases, and RI detection has been used for TDA performed with HPLC instrumentation,
but these examples required detection volumes on the order of 10 µL, which eliminates the
key advantages of small sample volumes and reduced analysis times in TDA [62, 101, 102].
Saetear et al. developed a backscattering interferometry (BSI) approach to improve RI detection
in TDA with nanoliter sample volumes [89]. A selection of poly- and monosaccharides, which
present a significant detection challenge due to low UV absorbance, were characterized by TDA
using the BSI technique in a commercial CE instrument. Determinations of D gave an average
RSD of 2%, demonstrating high repeatability in the TDA-BSI analyses of non-UV absorbing
molecules. In continuation of this study, Leclercq et al. investigated a UV-photooxidation (UVPOD) detection mode for TDA of polysaccharides and compared results to the BSI method, as
detection sensitivity of TDA-BSI is relatively low (LOD ≈ 50 – 80 mgL−1 ) [22]. RH values
for a selection of polysaccharides were determined by TDA-BSI and TDA-UV-POD with an
average relative difference in RH between the two detection modes of 2% and an RSD below
3%. Additionally, detection sensitivity of TDA-UV-POD for pullulans and dextrans was greater
than that of TDA-BSI (LOD = 40 mgL−1 and 50 – 60 mgL−1 , respectively). These works expand
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Figure 3.7: Comparison of A) DLS measurements for hydrodynamic diameters and B)
TDA measurements for RH of pepsin-coated GNPs at varying concentrations of pepsin.
While increasing diameter of pepsin-functionalized GNPs was expected with increasing pepsin
concentration, DLS did not resolve the small size differences of bioconjugates prepared at
various pepsin concentrations. TDA resolved the trend of increasing RH with increasing pepsin
concentration. Adapted from Talanta, Vol. 167, Markus Holdrich, Siyao Liu, Markus Epe, Michael
Lammerhofer, Taylor dispersion analysis, resonant mass measurement and bioactivity of pepsincoated gold nanoparticles, 67-74, Copyright (2017), with permission from Elsevier.
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the applications of TDA to applications requiring universal detection modes.

Characterizing the degradation products of biopolymers is essential for understanding the fate
of these materials in biomedical applications. The application of TDA to monitoring hydrolytic
degradation of a fifth generation dendrigraft poly-L-lysine (DGL G5) has been described [60].
Using three different approaches – curve fitting, cumulant series expansion, and constrained
regularized linear inversion - RH values were obtained at different degradation times. The RH
value for the enzymatic degradation of DGL n corresponds to the RH of the n − 1 generation,
elucidating structural and behavioral information about the polymer and enzyme, such as reaction
kinetics and degradation process. Other biopolymers, such as natural rubber [103], polyplexes
[21], and the influence of ionic strength[104] on these systems have also been studied by TDA.

3.9

Conclusion

In this review, we aimed to illustrate TDA as a powerful sizing technique that offers comparable
sizing performance with reduced sample consumption and often improved detection sensitivity as
compared to more common sizing techniques such as DLS, SEC, or various imaging approaches.
First, we offered a tutorial on the fundamental principles that allow TDA to achieve calibrationfree sizing of analytes across a wide range of RH , with an emphasis on the reduced sample
consumption and analysis times that result from utilizing fused silica capillaries. We continued
by highlighting relationships between operating parameters, such as u and Rc , and the critically
important Taylor conditions. Our intention was to acquaint those seeking to utilize TDA with the
careful consideration needed to design effective TDA experiments. Our discussion continued by
looking at methods for applying TDA to sample mixtures, first via algorithmic approaches, then
by looking at the integration of CE and TDA. Finally, we presented a selection of reports that
demonstrate TDA applied to complex challenges in bioanalysis and materials science.

TDA is a particularly attractive analytical method because it achieves calibration-free sizing
across an impressive dynamic range (ca. Å - µm) while utilizing nL sample volumes and
straightforward and accessible instrumentation. We see a valuable opportunity to expand the
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adoption of this technology within the broader separation science community. Meeting that
opportunity requires effort in a few areas. First, wider dissemination of the principles and
capabilities of TDA are needed, towards which we offer the current tutorial review. Second,
navigating the relationship between operating parameters and meeting the Taylor conditions
is a barrier to entry for those with little or no prior experience in TDA. This barrier would
be substantially lowered by making available adaptable, open-source calculation tools. Third,
although TDA can be readily achieved with commercial CE instrumentation, the cost of these
instruments is not trivial, and their capabilities far exceed the minimum requirements for typical
TDA analysis. Therefore, those without a CE instrument may not be inclined to acquire one for
the sole purpose of TDA, and those with a CE instrument may find its broader capabilities put to
more efficient use for other purposes. A few TDA-specific instruments are commercially available,
but the cost may be yet another barrier to entry. Ultimately, TDA is a mechanistically simple
measurement to implement, which may be amenable to the development of low-cost, open-source
hardware that will enable wide adoption of this powerful analytical method. We believe that wider
adoption of TDA will enable new dimensions of analysis across various sub-fields of analytical
chemistry and measurement science.

Currently, there are few automated capillary systems commercially available that have sizing
capabilities based on Taylor dispersion. Because of its inherent ability to control pressure flow
within a capillary, TDA is commonly performed within commercial CE instrumentation. However,
as described in Chapter 1, the use of CE instrumentation comes with its own set of limitations
for dual-point fluorescence detection. Chapter 4 will describe the development of a novel 3D
printed instrument for performing TDA in fused silica capillaries and high sensitivity laser-induced
fluorescence detection.
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Chapter 4
A 3D Printed Instrument for Taylor Dispersion Analysis with Two-point Laser-induced
Fluorescence Detection
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4.1

Abstract

Precise control of the size of various types of biological and pharmaceutical compounds is often
critical. Standard methods for size characterization, such as dynamic light scattering, are ultimately
sample intensive and do not provide the sensitivity needed for low volume, low concentration
biological systems. There is a need for more sensitive, accurate, and straightforward analytical
tools for size analysis. Taylor dispersion analysis (TDA) is a proven analytical method for size
determination without the need for calibration and utilizes only nL - pL of sample. In TDA, average
diffusion coefficients are determined by characterizing band broadening of an analyte under wellcontrolled laminar flow conditions, allowing for the determination of hydrodynamic radius. Here,
we describe the design and optimization of a 3D printed instrument for TDA with dual-point laserinduced fluorescence (LIF) detection. The instrument utilized a fully 3D printed eductor as a
vacuum source for precise and stable pressure driven flow within the capillary, evidenced by a
linear response in generated static pressure to applied gas pressure (R2 = 0.997) and a 30-fold
improvement in stability of static pressure (0.05% RSD) as compared to a standard mechanical
pump (1.53%). Design aspects of the LIF detection system were optimized to maximize S/N
for excitation and emission optical axes, and high sensitivity was achieved by an 80 pM limit
of detection for the protein R-phycoerythrin and low-nM limits of detection for three additional
fluorophores. The utility of the instrument was demonstrated via sizing of R-phycoerythrin at pM
concentrations, and evaluation of synthetic liposome preparations.
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4.2

Introduction

Macromolecular products for biological and pharmaceutical applications, such as liposomes,
nanoparticles, engineered proteins, and drug delivery systems, can require precise control over
product size to achieve desired material properties.

The design and development of new

macromolecular materials can benefit from the availability of simple, rapid, sensitive, and high
accuracy analytical methods for size characterization.

Many common size characterization

techniques require extensive method development, tedious sample preparation, large sample
volumes, or lengthy analysis times [1]. Two widely used methods for size characterization are
dynamic light scattering (DLS) and size exclusion chromatography (SEC). DLS provides rapid
measurements with limited sample preparation, but is biased in sensitivity towards large particles
and aggregates [2]. For example, Hawe et al. used DLS to measure a range of concentrations
(0.05 - 50 mg mL−1 ) of several proteins and peptides [3]. Though DLS successfully sized the
antibody drug adalimumab (5 - 6 nm) at the lowest concentration, it was not possible to size
the peptide oxytocin (∼ 0.8 nm) at lower concentrations. This was due to the influence of dust
or excipients in the sample, which resulted in inaccurate and inconsistent hydrodynamic radius
(RH ) determinations ranging from 6.9 - 130 nm for oxytocin. SEC requires calibrations and is
susceptible to analyte-column interactions dependent on mobile phase composition [4]. Ricker
and Sandoval reviewed various operational parameters, such as column length, flow rate, sample
volume, and mobile phase conditions, that affect SEC separations [5]. They demonstrated the
susceptibility of SEC methods to deleterious effect related to mobile phase ionic strength and pH
while analyzing mouse myeloma antibodies with differing charges. At pH 7, the strongly basic
antibody showed broadening and non-specific retention in the column at lower ionic strengths
(20 and 50 mM) while the weakly basic antibody begins to broaden and be retained at higher
ionic strengths (600 and 1000 mM). Such electrostatic and hydrophobic effects exhibited in SEC
columns ultimately result in inaccuracies in measured RH . Though various solvent additives and
organic modifiers have been explored and employed for SEC separations to suppress adsorption
and hydrophobic interactions [4, 6, 7, 8, 9], extensive method development is still often required
to obtain accurate sizing.
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Taylor dispersion analysis (TDA) offers similar sizing capabilities to DLS and SEC, while
utilizing nL sample volumes and without the need for size-based calibration or comparison to
size standards. First described in 1953 [10], TDA enables direct determination of molecular
diffusion coefficients across a wide dynamic range of hydrodynamic radii from Å to µm. Taylor
dispersion arises from the interplay of radial diffusion within a cylindrical flow channel and the
parabolic velocity flow profile of pressure-driven laminar flow in such flow systems. As a result,
a sample zone will spread out axially, the degree of which can be observed by characterizing
band broadening of a sample zone under continuous flow. Diffusion coefficient is inversely
proportional to an analyte’s hydrodynamic radius, and therefore the rate of band broadening
by Taylor dispersion is influenced directly by the analyte’s hydrodynamic radius. TDA is a
mathematical framework for extracting diffusion coefficients directly from the observed rates of
band broadening due to Taylor dispersion.

TDA has evolved from studying gaseous diffusion coefficients in large tubes [11] to capillarybased solution phase measurements of small molecules [12, 13], macromolecular complexes
[14, 15, 16], and even micron-scale particles [17]. In TDA, reduced tubing diameter is associated
with reduced analysis times. The time required to generate a measurable change in dispersion
for measurements of D is proportional to the square of the tubing radius. Thus, small molecule
analytes flowing through a tube of 1 mm radius would require several hours to produce the same
degree of Taylor dispersion observed in a 50 µm radius capillary in only minutes [18]. Reduced
analysis times, improved precision of flow rate control, and low sample consumption have all
motivated the use of capillary electrophoresis (CE) instrumentation for performing TDA.

Highlighting the need for continuous flow velocity in TDA, Sharma et al. described the effects
of the initial ramp in flow velocity that occurs upon pressure application in CE instruments [18].
Discontinuous flow velocities resulting from stopping flow for sample injection introduced significant error in determining diffusion coefficients, requiring empirical mathematical corrections.
Measurement errors as high as 40% have been attributed to these sub-optimal flow conditions [19].
To address these limitations, dual-point detector schemes have been developed that allow TDA to
be conducted under continuous flow [12, 20, 21, 22]. Chamieh et al. addressed the engineering
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challenge of integrating dual-point detection into commercial CE instrumentation by modifying
the optical detection interface within an Agilent CE cassette such that the capillary could be
looped within the cassette and pass the UV detection point twice [21]. Diffusion coefficients
and corresponding hydrodynamic radii measurements for 10 mM caffeine, 75 µM BSA, and 75
µM HSA were in agreement with literature values to within 5%, however this detection scheme
resulted in substantially reduced sensitivity for UV absorbance detection. Our group developed an
LED-induced fluorescence detection system for integration into commercial CE instrumentation,
enabling dual point detection with higher sensitivity than is possible by UV absorbance detection
[22]. A miniature detection head was 3D printed to house an excitation source and excitation and
emission optics which enabled the integration of two detectors within a single capillary cassette.
Multivariate optimization of operating conditions, such as LED current, yielded a detection limit of
613 ± 13 pM for fluorescein. While LED-induced fluorescence offered improved sensitivity over
UV absorbance detection, these detection limits were still modest in comparison to laser-induced
fluorescence (LIF) detection, a common detection mode for high sensitivity CE assays.

The evolution of TDA towards commercial CE instrumentation has enabled fast analysis times
and precise control over flow rates, but it has also presented engineering challenges, especially
with regard to integrating dual-point detection. None of the existing approaches to dual-point
detection in commercial CE instruments can achieve detection limits comparable to that of CE-LIF.
Therefore the substantial expense of acquiring CE instrumentation is accompanied by a significant
compromise in quantitative performance when applying that instrument to TDA. An improved
approach to instrumentation for capillary TDA would offer precision flow control, dual point LIF
detection, and, to improve accessibility and adoption of TDA, dramatically reduced cost compared
to available commercial CE instrumentation.

To deliver improved instrumentation for capillary TDA, and to enable wider adoption of
TDA as a sizing technique, in the present work we describe the design and optimization of a
3D printed instrument for TDA with dual-point LIF detection. The instrument utilized a fully
3D printed eductor as a vacuum source for precise and stable pressure driven flow within the
capillary. An LIF detection system was developed based on a 3D printed architecture for holding
90

various optical elements in alignment with the capillary. Design aspects of the LIF detection
system were optimized to maximize S/N, and the utility of the high sensitivity TDA instrument
was demonstrated via protein sizing at pM concentrations, and evaluation of synthetic liposome
preparations.

4.3

Theory

TDA is a powerful sizing technique that is surprisingly underutilized within the separation science
community. Therefore, we offer here a brief primer on the underlying theory of TDA to facilitate
implementation by others of the instrumentation described elsewhere in this work.

To enable direct determinations of diffusion coefficient by characterizing the rate of band
broadening, two stipulations are placed on the experimental flow conditions, collectively termed
the “Taylor conditions”. The first Taylor condition ensures that the rate of band broadening due
to longitudinal diffusion is negligible compared to the rate of band broadening due to Taylor
dispersion. To achieve this, the rate of advection must be sufficiently greater than the rate of
diffusion, which is satisfied when the Peclet number (Pe) is greater than 69 [23], defined by the
following equation [18]:

Pe =

uRc
D

(4.1)

where u is the linear flow rate, Rc is the radius of the capillary, and D is the molecular diffusion
coefficient. Note that since this is a threshold condition, it does not require foreknowledge of D
for a particular analysis, only a defined upper bound above which the accuracy of D measurements
will diminish. Still, this condition warrants careful consideration when defining parameters for
TDA experiments.

The second Taylor condition ensures that the sample remains in flow long enough to observe
substantial band-broadening via Taylor dispersion [10]. This condition is satisfied when the
unitless time parameter (τ ) is greater than 1.4, with defined as:
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τ=

DtR
Rc2

(4.2)

where tR is the requisite residence time of the sample plug in flow. This equation illustrates that
by reducing Rc , analysis times are also reduced, which has encouraged the use of fused-silica
capillaries in modern TDA applications.

The Diffusion coefficient (D) is determined directly from the observed rate of band broadening
via the Taylor-Aris equation:

D=

Rc2 td
24σ 2

(4.3)

where σ 2 is the variance of the resulting peak that has undergone band broadening via Taylor
dispersion.

One counterintuitive consequence of the Taylor-Aris equation is that by Taylor

dispersion low D corresponds to higher rates of band broadening. This is the opposite trend to
that observed by longitudinal diffusion, and highlights the importance of satisfying the Taylor
conditions.

Due to considerations discussed above, two-point detection is an effective way to improve
accuracy in TDA by ensuring stable and continuous flow for the duration of tR . Therefore, for
two-point detection, the Taylor-Aris equation is modified as follows [24]:

D=

Rc2 (t2 − t1 )
24(σ22 − σ12 )

(4.4)

where t1 and t2 are the peak arrival times at detectors 1 and 2, respectively, and σ12 and σ22 are
the peak variances as observed at detectors 1 and 2, respectively. Using a spherical approximation
of molecular geometry, D is transformed to hydrodynamic radius (RH ) via the Stokes-Einstein
relation [25]:

RH =

kB T
6πηD
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(4.5)

where kB is the Boltzmann constant, T is temperature, and η is the dynamic viscosity of the
solution.

4.4
4.4.1

Materials and Methods
Reagents and materials

Rhodamine 6G 99% was ACROS Organics brand from Fisher Scientific (Suwannee, GA).
R-Phycoerythrin was purchased from AnaSpec, Inc.

(Fremont, CA), AlexaFluor 532 was

purchased from Thermo-Fisher Scientific (Waltham, MA), and CF532 was purchased from
Biotium (Hayward, CA). Phosphate buffered saline (PBS) was Fisher BioReagents brand and
purchased from Fisher Scientific (Suwannee, GA). All aqueous solutions were prepared using
DI water. Fused silica capillary was Polymicro brand from Fisher Scientific (Suwannee, GA).

Phospholipids, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Liss Rhod PE) were purchased from
Avanti Polar Lipids, Inc. (Alabaster, AL).

4.4.2

3D printing

An Anycubic Photon-S Digital Light Processing Stereolithography (SLA) 3D printer was used to
print the eductor with a Peopoly Moai resin (Matter Hackers, Burbank, CA) with a layer height of
0.1 mm, 80 s bottom layer exposure time, and 30 s exposure time to completion. A Form 3B SLA
3D printer was used to print the capillary cartridges, alignment tool, and fully functional instrument
with Tough 2000 resin (RS-F2-TO20-01) using the default resin settings and a resolution set to 50
µm.

4.4.3

Eductor-driven pressure system

To characterize the vacuum pressure system, the eductor component of the instrument was 3D
printed separately. The gas inlet barb fitting was connected to an in-house nitrogen line and the
vacuum barb fitting was connected to a 5 ft length of 1/8” i.d., 1/4” o.d. vinyl tubing. The end
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of the tubing was submerged into a beaker containing Milli-Q water to form a water column for
static pressure measurements. For vacuum pressure characterization, the nitrogen line was set to
varying pressures (2-10 psi) and mmH2O was recorded by measuring the resulting level within the
water column. The corresponding values of mmH2O for each gas inlet pressure were converted to
units of psi for calibration plots. Eductors are ultimately controlled via volumetric flow rate of the
compressed gas source, thus the regulated gas pressure supply was calibrated to allow reporting
of volumetric flow rate as an independent variable. A 1000 mL graduated cylinder was filled with
water and inverted within a tank of water. The effluent of the nitrogen supply line was captured
within the graduated cylinder at various regulated pressures (2 - 10 psi), and the rate of water
evacuation from the graduated cylinder was recorded on video to determine the volumetric flow
rate of nitrogen gas as a function of regulated gas pressure.

For pressure stability characterizations, video was recorded via smartphone camera of the water
column level at 10 vacuum pressure settings. ImageJ was used to track the pixel location of the airwater interface over time, and a MatLab script written in-house was used to convert the sequence
of tracked pixel locations to height of the water column in mm via a calibration image that included
a ruler in the field of view for length calibration purposes.

4.4.4

LIF detection system

Two 532 nm collimated laser-diode-pumped laser modules were purchased from Thorlabs Inc.
(CPS532, Newton, NJ). Laser excitation light was directed to the detection windows of the
capillary via a 9.0 mm 20 mm FL N-BK7 plano convex lens (LA1472, Thorlabs Inc., Newton,
NJ) and internally printed pinhole aperture. Fluorescence emission was collected via 6.0 mm NBK7 ball lens (Edmund Optics Inc., Barrington, NJ) and 10 mm FL 25 mm diameter concave
mirror (43464, Edmund Optics Inc., Barrington, NJ) for transmission to a Hamamatsu H7828-50
Photomultiplier Module fitted with a 0.9 OD neutral density filter (NE09B, Thorlabs Inc., Newton,
NJ), 533/17 nm OD 6 notch filter (NF533-17, Thorlabs Inc., Newton, NJ), 580 ± 2, FWHM
10 ± 2 nm OD6 bandpass filter (FB580-10, Thorlabs Inc., Newton, NJ), 550 nm OD6 longpass
filter (FELH0550, Thorlabs Inc., Newton, NJ), 50 mm focusing lens (LA1131, Thorlabs Inc.,
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Newton, NJ), and 532 nm OD5 notch filter. Data acquisition via a USB DAQ module (USB6341, National Instruments, Austin, TX) with software written in-house in LabView (National
Instruments, Austin, TX).

4.4.5

Validation of TDA using model fluorescent molecules

Taylor dispersion experiments were carried out in a 25.5 cm length, 100 µm i.d./360 µm o.d. fusedsilica capillary with 15 cm window spacings. Samples of 20 nM AlexaFluor 532 and 10 nm, 5 nM,
1 nM, and 750 pM R-PE were prepared with 1X PBS buffer prior to the experiments. For each
run, the capillary was filled with 1X PBS buffer via eductor-driven vacuum flow. Before sample
introduction, buffer flow was stopped via pneumatic valve, which allowed the replacement of the
buffer vial with the sample vial without introducing air bubbles into the capillary. Samples were
injected by momentarily resuming eductor flow via the pneumatic valve. Flow was stopped again,
and sample vial was replaced with buffer vial, before eductor flow was resumed for the remainder
of the measurement. Each peak was fitted as a Gaussian function, and differences in arrival time
and peak variance at the two detection points were used to calculate diffusion coefficient (eq.
4.4) and hydrodynamic radius (eq. 4.5). Values were tested for outliers using Grubb’s test for
outliers. At a confidence interval of 95%, 2 data points were eliminated as outlying values from
data collected with 5 nM and 1 nM R-PE.

4.4.6

Lipid vesicle preparation

DOPC lipid solutions containing 1% w/w of Liss Rhod PE were prepared to a final lipid
concentration of 2 mg mL−1 . Chloroform solvent was evaporated from the lipid mixture by N2
stream for 10 minutes and placed on vacuum overnight. The dry lipid film was hydrated with PBS
buffer for 1 hour. The buffer was prepared by adding 0.1% w/w bovine serum albumin (BSA)
(Fisher Scientific) to 1X PBS. For sonicated vesicle preparation (diameter ca. 50 nm) the lipid
solution was sonicated for 2 hours using a bath ultrasonic cleaner (Branson 2800). To produce
vesicles of larger diameters, hydrated lipid solutions were subjected to 10 freeze-thaw cycles
before 15 passes of extrusion through 200 nm pore diameter polycarbonate membrane filters at
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room temperature using a mini extruder (Avanti Polar Lipids Inc., Alabaster, AL).

4.4.7

Sizing of synthetic lipid vesicles by TDA-LIF

Taylor dispersion experiments for the population of vesicles prepared via sonication were carried
out in a 25.5 cm length, 100 µm i.d./360 µm o.d. fused-silica capillary with 15 cm window
spacings. For the 200 nm vesicles prepared via membrane extrusion, experiments were carried out
in a 35.5 cm length, 100 µm i.d./360 µm o.d. fused-silica capillary with 25 cm window spacings.
The experimental procedure for sample injections and post-analysis were identical to that described
above for model fluorescent molecules. Values were tested for outliers using Grubb’s test. At a
confidence interval of 99%, 1 data point was eliminated as an outlying value for data collected with
the 50 nm vesicle population.

4.5

Results

Commercial CE instrumentation provides convenient and precise control of flow rates in capillaries, but significant barriers to adopting TDA exist including instrumental cost and the lack of
available dual-point LIF detection. To reduce these barriers, we have developed a 3D printed
instrument for TDA that combines accurate capillary positioning, precise flow control at low flow
rates, and two-point LIF detection.

4.5.1

Capillary positioning

Precise control of capillary length and the distance between detection points are key to accurate
measurements by TDA because they influence the precision of tR and u, both of which are critical
to satisfying the Taylor conditions. The instrument design utilized the geometric precision of
3D printing to achieve accurate detection window positioning via capillary cartridges designed
for three specific detection window spacings: 10 cm, 15 cm, and 25 cm (Fig. B.1). To prepare
a capillary cartridge with appropriately spaced detection windows, an accompanying 3D printed
alignment tool was produced (Fig. B.1) to indicate precise locations of detector windows and
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cutting locations (Fig. B.1, red arrows) at the capillary inlet and outlet. Capillary cartridges
mounted to the alignment tool with the same dovetail joint utilized on the instrument body. Thus,
once the capillary is prepared the cartridge is removed from the alignment tool, placed onto the
instrument body, and secured with a 3D printed key (Fig. B.1, red box) to ensure that the placement
of the detection windows aligns appropriately with excitation and detection optics within the 3D
printed LIF detector system.

While the cartridge and alignment tool ensured appropriate detection window positioning in
the longitudinal dimension of the capillary, lateral positioning of the capillary within the detection
volume defined by the focal volumes of excitation and collection optics was also critical. Typical
consumer grade 3D printing resolution is not sufficient to produce features small enough to
define lateral positioning of the 360 µm o.d. capillary within the detection volume. While this
is well within the capabilities of high cost, high resolution 3D printing, the present technology
was intended to improve access to TDA, and therefore we designed the instrument with low cost
commercial 3D printers in mind. A simple approach to achieve appropriate lateral positioning was
the use of capillary tubing sleeves of the type utilized to interface capillaries with 1/16” fingertight
fittings. Thus, the opening to accept the capillary into the 3D printed detectors was sized to fit the
outer diameter of these tubing sleeves, and then sleeves were inserted to ensure that the capillary
was centered on the intended axis through the middle of the detector (Fig. B.2).

4.5.2

Eductor-driven pressure system

Achieving accurate TDA with relatively short capillary lengths required precise and stable control
of pressure-driven flow at low nL min−1 volumetric flow rates. At the core of the instrument
design is a fully 3D printed eductor, designed to generate sub-ambient pressure at the capillary
outlet and, therefore, drive pressure-driven flow through the capillary with an open and accessible
capillary inlet. Eductors operate on the Bernoulli principle, and have been employed in various
applications, including coupling digital microfluidics to electrospray mass spectrometry [26] and
for the generation of liposomes [27]. The internal geometry of the 3D printed eductor can be seen
in (Fig. 4.1A), and consists of two coaxial nozzles nested such that compressed air flowed through
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the internal nozzle entrains flow through the external nozzle, generating modest vacuum pressure
to induce flow within the capillary. As highlighted by the benefits of two-point detection for TDA,
stable continuous flow rates are essential for accurate TDA. (Fig. 4.1B) illustrates static vacuum
pressure vs. time for a mechanical diaphragm pump (blue) as compared to that achieved by the 3D
printed eductor (black). A 30-fold improvement in stability of static pressure is observed for the
3D printed eductor (0.05% RSD) as compared to the mechanical pump (1.53% RSD). (Fig. 4.1C)
shows that highly stable static pressures (RSD < 0.1%) were produced with the eductor system
across a range of static vacuum pressures from 0.2 to 1.7 psi below ambient pressure. Ultimately,
the eductor system must provide precise control of vacuum pressures to allow flow conditions to be
tuned to meet Taylor conditions for various analyses. (Fig. 4.1D) shows the resultant static vacuum
pressure as a function of volumetric flow rate of compressed air applied to the eductor inlet (R2 =
0.997). Precise control of static pressure produced by the eductor enabled precise control of flow
rates in the capillary for TDA experiments.

4.5.3

Optimized design of the LIF detection system

To reduce the collection of scattered excitation light, the optical design collects fluorescence
emission 90◦ from the excitation path as illustrated in Fig. 4.2A. Two LIF detectors of identical
configuration are integrated into the instrument design. Each detector consisted of a housing to
mount a low cost 532 nm diode laser module as an excitation source, and a concave mirror and ball
lens as the primary optics for collecting fluorescence emission (Fig. 4.2C). The mirror and ball lens
were positioned to collimate collected emission light, which was transmitted via a conventional 25
mm lens tube to a PMT for signal transduction. The PMT was fitted with a planoconvex lens to
focus collimated emission light onto the PMT active area, and a 532 nm notch filter to selectively
reduce the intensity of scattered excitation light. Despite the notch filter fitted at the PMT, aberrant
scatter of the laser sources was a significant hurdle to achieving appropriate fluorescent detection
limits with this detector design. Therefore, we set out to optimize the detector design to reduce
scatter and improve overall S/N for detected fluorescence signals.
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Figure 4.1: Eductor pressure characterization. (A) CAD illustrations of the eductor in cross section
(i) and 3D with transparancy (ii) to illustrate internal geometry. Arrows indicate the direction of
flow for compressed air/N2 (solid arrows), entrained vacuum flow (dashed arrows) and exhaust
flow (dotted arrow). (B) Comparison of vacuum pressure stability over time for eductor (black
trace, 0.05%) and mechanical pump (blue trace, 1.53% RSD). (C) Relative standard deviation
percentages in static pressure stability over a range of applied inlet gas pressures. Average RSD
= 0.055%. (D) Calibration of the vacuum static pressure generated by the eductor for an applied
inlet gas volumetric flow rate.
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Figure 4.2: Design illustrations of 3D printed TDA instrument. (A) Rendering of 3D CAD model
illustrating internal geometries. (B) Photograph of the fully assembled instrument, mirrors, ball
lenses, capillary, and capillary cartridge. (C) Schematic illustration of the optical design in the
optimized excitation and emission axes.
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Using a 500 nM Rhodamine 6G solution as a model fluorophore, we observed the resultant
S/N for various design configurations, and results of this optimization are illustrated in (Fig. 4.3).
The emission axis was optimized by characterizing the serial addition of various optical filters
(Fig. 4.3A and B). In addition to the PMT outfitted with a focusing lens (PCX, FL = 50 mm)
and notch filter (533/17 nm, OD 6), the emission axis initially included the appropriate bandpass
filter (580 ± 2, FWHM 10 ± 2 nm OD6), however under this configuration the net signal of
fluorescence and background exceeded the dynamic range of the PMT. Thus, the first design
modification evaluated, termed “Design A”, added a neutral density filter (OD 0.9) to attenuate
overall signal intensity to within the dynamic range of the PMT. This OD value was selected based
on observing S/N with 500 nM Rhodamine 6G for various OD values (data shown in Fig. B.3). In
an attempt to further selectively reduce the effect of laser scatter, Design B added a longpass filter
(550 nm, OD6). Design C added an additional notch filter (532 nm, OD5), resulting in a dramatic
decrease in background intensity and a commensurate increase in S/N. Since the majority of gains
in S/N from design A to Design C appeared to be attributed to the additional notch filter, Design D
evaluated simplifying the emission axis by removing the longpass filter. Surprisingly, this resulted
in dramatic reduction of S/N, and led us to conclude that the maximum filtering approach (i.e.
Design C) was optimal among the conditions evaluated. Although this implies that further filtering
may have resulted in continued improvements of S/N, in our judgement the added cost of additional
filtering was counter to the intended purpose of producing an accessible TDA instrument, and
we anticipated the that sensitivity provided by Design C would be sufficient to achieve practical
detection limits for various common fluorophores in this wavelength regime. Still, more work in
this area may further improve S/N in this LIF detector design.

The design of the excitation optical axis was also considered on the basis of maximizing
signal intensity and reducing laser scatter. A 9 mm diameter plano-convex lens (FL = 20 mm)
was positioned in the excitation path to focus the laser onto the capillary detection window,
maximizing incident intensity for fluorescence excitation. We evaluated spatial filtering of the
laser source with pinholes of various diameters (0.4-2.5 mm) as a means to reduce the intensity
of scattered excitation light collected in the emission axis. The pinholes were positioned between
the laser source and the focusing lens to effectively attenuate the beam diameter of the laser, and
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Figure 4.3: Excitation and emission axis optimization. (A) Design configurations included in S/N
optimization labeled A through D. (B) Results of emission axis optimization, including comparison
of S/N and background counts. (C) S/N and background counts as a function of pinhole diameter
in the excitation axis. A pinhole diameter of 1.5 mm produced the greatest S/N ratio. At 2.5 mm
pinhole diameter, 500 nM analyte concentration produced a detector response that exceeded the
dynamic range of the PMT, therefore the data shown is a 2-fold extrapolation of data collected for
an analyte concentration of 250 nM.
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S/N and background intensity were investigated as a function of annulus diameter (Fig. 4.3C).
Unsurprisingly, we observed increased background due to scatter with increasing beam diameter.
Similarly, we observed increasing fluorescent signal with increasing beam diameter (data not
shown), as the increased beam diameter represented an increase in excitation intensity at the
focused detection point. Increases in both signal and noise were balanced at an optimal S/N with
a pinhole diameter of 1.5 mm. This spatial filter was then incorporated into the final 3D printed
geometry of the instrument.

4.5.4

LIF detection limits

To evaluate the efficacy of the LIF detection system for various applications, we produced
calibration curves for 4 common fluorescent molecules compatible with 532 nm excitation:
Rhodamine 6G, R-Phycoerythrin (R-PE), AlexaFluor 532, and CF532 (Fig. 4.4). In each case
we observed a linear response over at least one decade of dynamic range. Importantly, these
experiments were designed to characterize detection limits, and therefore further work is needed to
evaluate the full linear and dynamic ranges for each fluorophore. The calculated LODs, based on
linear regression of the calibration data, were 15 nM, 80 pM, 1 nM, and 5 nM, for Rhodamine 6G,
R-Phycoerythrin (R-PE), AlexaFluor 532, and CF532, respectively. These detection limits offer
the prospect of analyte sizing by TDA at low and sub-nM analyte concentrations.

4.5.5

Validation of TDA using model fluorescent molecules

The printed capillary cartridge and alignment tool were used to prepare a 100 µm i.d. capillary
with 15 cm detection window spacings for a TDA demonstration on AlexaFluor 532 and R-PE.
First, a flow rate calibration was performed with the selected capillary size and window spacing to
determine the input eductor pressure needed to stay within the range of precise flow rate conditions
(Fig. B.4). Operating at a flow rate within the TDA regime, sample plugs were injected into the
capillary and the corresponding peaks were fitted to a Gaussian function (Fig. 4.5A). Figure 4.5A
and 4.5B illustrates the differences in band broadening between AlexaFluor and R-PE, respectively.
Raw data traces (gray) and Gaussian fits for detector 1 (red) and detector 2 (blue) are normalized
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Figure 4.4: Concentration calibration for (A) rhodamine 6G, (B) R-Phycoerythrin (R-PE), (C)
AlexaFluor 532, and (D) CF532. LODs were defined as S/N = 3 x standard deviation of the
baseline, and determined by linear regression to be 15nM, 80pM, 1nM, and 5nM for A - D,
respectively.
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and peak the centers are overlaid to visualize the relative degree of band broadening. TDA of
AlexaFluor 532 determined an RH of 0.87 ± 0.35 nm (n=5). TDA was performed with 10 nM,
5 nM, 1 nM, and 750 pM R-PE providing RH values of 5.48 ± 0.40 nm (n=11), 5.64 ± 0.3 nm
(n=13), 5.75 ± 0.14 nm (n=12), and 4.87 ± 0.98 nm (n=14), respectively (Fig. 4.5B). We attribute
the large variance in measured RH at 750 pM to imprecision of the gaussian fit resulting from a
relatively low S/N. As a result, the 750 pM data was statistically different from the 1 nM data at
the 95% confidence level. Still, the median result of the 750 pM data set was 5.03 nm, which
represents a 10.7% error from the population mean observed across all other concentrations (5.63
nm), and suggests some degree of efficacy in protein sizing even at sub-nm concentrations. TDA
results were within reasonable agreement with MacColl et al., who determined a hydrodynamic
radius of 5.54 ± 0.18 nm for R-PE by DLS [28].

4.5.6

Sizing of synthetic lipid vesicles by TDA-LIF

To illustrate the utility of the TDA-LIF system towards potential pharmaceutical preparations, the
instrument was applied to the sizing of synthetic lipid vesicles prepared by two different methods.
First, vesicles prepared by sonication were analyzed using 100 µm i.d. capillary with a 15 cm
detection window spacing (Figure 4.6A). TDA, resulted in an RH measurement of 22 ± 1 nm
(n=4), consistent with previous reports of liposomes prepared in this manner (c.a. 7.5 - 25 nm
[29]).

Equation 4.2 indicates that longer analysis times are required to meet the Taylor conditions for
analytes with smaller diffusion coefficients. Thus, for TDA of liposomes prepared via extrusion
through 200 nm track etched filter membranes, 25 cm detection window spacing was used to meet
this criteria. TDA of extruded vesicles determined a RH measurement of 107 ± 21 nm (n=3) was
obtained, which agrees well with previous reports of extruded vesicles at or slightly larger than the
diameter of extrusion pores [30].
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Figure 4.5: Dual-point detection TDA of (A) AlexaFluor 532 (20 nM); and (B) R-PE (5 nM). Raw
data (gray) Gaussian fits (red and blue) are each normalized to a relative fluorescence scale, and
the peaks are aligned on the time axis to illustrate relative differences in band broadening between
the two model fluorophores. (C) Size determination for R-PE at various concentrations, illustrating
protein sizing at low-to-sub nM concentrations.
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Figure 4.6: Dual-point LIF detection TDA of lipid vesicle preparations. (A) Vesicles prepared
by sonication measure RH = 22 ± 1 nm; (B) Vesicles prepared by extrusion through 200 micron
membrane pores measure RH = 107 ± 21 nm. Peaks are plotted in the same manner described for
Figure 5.
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4.6

Conclusion

Size characterization is an important analysis across many fields of materials science, and
especially for the analysis of biomacromolecules and pharmaceutical preparations. Shortcomings
of common methodologies like DLS and SEC, present a need for rapid, straightforward, sensitive,
and inexpensive methods for size characterizations. TDA meets most of these needs, but it is
commonly performed using expensive CE instrumentation with UV absorbance detection that
substantially limits sensitivity. We have developed a low-cost 3D printed instrument for TDA
in fused silica capillaries that enables two-point LIF detection with low nM to mid pM LODs.
Still, further work in this area remains to achieve LODs competitive with the highest sensitivity
LIF systems. The system relies on low cost 532 nm laser diode modules, which limits fluorophore
selection to labels that are not optimum for the lowest possible fluorescent LODs. Additionally, the
emission axis relies on multiple dielectric optical filters that significantly drive up the overall cost
of the system. Future work in this area will focus on improved optical efficiency, and achieving
more effective scatter rejection at reduced cost via spatial and spectral filtering.

The integration of an eductor-based pressure system enabled precision flow rate control with
exceptional pressure stability, which is needed for accurate TDA. Since the pressure system is
completely 3D printed and includes no moving parts, it presents a robust and exceptionally low
cost approach to pressure driven flow for capillary-based analyses. Ultimately, the instrument was
shown to be effective for protein sizing at low-to-sub nM concentrations, and was able to resolve
size differences that result from various liposome preparation methods. We anticipate that making
this instrument available via digital distribution of the 3D printable models will facilitate wider
access to the powerful sizing capabilities of TDA.
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5.1

Summary

New analytical tools are necessary for investigating spatiotemporal secretion dynamics of exosomes. A focus of this work has been towards the development of a novel proximity vesicle fusion
assay for the determination and quantification of exosome contents. The analytical challenges
addressed in this dissertation involve the lack of sensitivity and selectivity of common analytical
techniques for the characterization of exosome contents and size, as well as the uncertainty in assay
sensitivity, which proved difficulty in isolating which variables were contributing to signal. Taylor
dispersion analysis (TDA) offers the advantage of solution-phase size characterizations in subnL volume samples without the need for calibrations or internal standards. These advantages are
desirable for the volume-limited, low-concentration biological samples that are under investigation.
The remainder of the work described within focuses on the application of TDA to our research
goal and the development of new tools and assays that contribute to the utility of size-based
measurements via TDA.

5.2

Proximity vesicle fusion assay

The primary objective of the research goals for this dissertation was to develop a novel assay
in which vesicle fusion combined with molecular recognition of exosome membrane proteins
would facilitate encapsulated analytical reactions and high sensitivity detection of vesicle contents,
enabling specific assay of biomolecules encapsulated by exosomes. Early progress was made
towards a proof-of-concept model system, but concerns surrounding which variables were
contributing to signal were raised. For example, increased fluorescence signal could have been
indicative of various states of the system: vesicle fusion and content mixing, vesicle aggregation,
or vesicle content leakage. The uncertainty in our results led to the new perspective of analyzing
our system by making size-based characterizations, which led our research in a new direction.
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5.2.1

Preliminary results

Future work would include revisiting the original proximity vesicle fusion assay and characterizing
the system using our developed 3D printed TDA instrument. Small changes in RH determinations
by TDA would confirm the state of the assay (i.e. fusion, aggregation, or leakage). Fusion of EMs
(50 nm diameter) with RVs (200 nm diameter) would result in an RH measurement slightly above
100 nm, vesicle aggregation would result in RH >> 200 nm, and content leakage would result in
low RH values that are comparable to that of the fluorescent marker encapsulated in RVs (<< 200
nm).

The application of our TDA instrument for making size characterizations of the proximity
vesicle fusion assay has been demonstrated by preliminary experiments. DOPC lipid solutions
containing 1% w/w of Liss Rhod PE and 1% w/w of biotinyl cap PE were prepared to a final lipid
concentration of 2 mg mL−1 . Chloroform solvent was evaporated from the lipid mixture by N2
stream for 10 minutes and placed under vacuum for 3 hours. The dry lipid film was hydrated with
PBS buffer for 1 hour. The buffer was prepared by adding 0.1% w/w bovine serum albumin to 1X
PBS. The lipid solution was sonicated for 2 hours using a bath ultrasonic cleaner. Taylor dispersion
experiments were carried out with a diluted sample (1:1 of initial preparation) in a 25.5 cm length,
100 µm i.d./360 µm o.d. fused-silica capillary with 15 cm window spacings. The experimental
procedure for sample injections and post-analysis were identical to that described in Chapter 4.4.5.
To the same vesicle sample, streptavidin was added with approximately a 1:12 molar ratio to the
biotinylated lipid in the vesicle sample. TDA was performed on the vesicle-streptavidin system
as described above. Results of the TDA experiments before and after the addition of streptavidin
are shown in Fig. 5.1, where fitted peaks from both detection points are normalized and overlaid
to visualize band broadening. Though a change in band broadening between detection points
before and after the addition of streptavidin may not be visually obvious, the difference in RH
determinations is evident. TDA of the prepared population of vesicles determined an RH of 25 ±
6 nm (n=3), while after the addition of streptavidin determined an RH of 40 ± 5 nm (n=3).
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If the vesicle population is assumed to have equal radii of 25 nm (mean value), the number of
vesicles needed to fuse to produce a larger vesicle of 40 nm (mean value) radius can be estimated
based on the respective volume or surface area of the spherical vesicles. However, given by the
equations for volume (V) of a sphere
4
∗ π ∗ r3
3

(5.1)

A = 4 ∗ π ∗ r2

(5.2)

V =
and surface area (A) of a sphere

where r is the radius, the volume and surface area of the vesicles will not grow at the same rate.
If either case is considered over the other to determine the number of smaller vesicles needed
to fuse to produce a larger vesicle, the system is necessarily left with excess lipid or excess
aqueous environment is needed after fusion. More experiments are needed to resolve both potential
mechanisms.

5.2.2

Future work

Though the preliminary data discussed above may suggest that our system is in the proposed
condition of total vesicle fusion, there is a challenge of resolving vesicle fusion from aggregation.
Two potential studies could lead to distinguishing between the two conditions: evaluation of
overall size and evaluation of the fusion/aggregation rate. Evaluating the size determinations
of the system would provide evidence suggesting fusion over aggregation, or vice versa. For
example, if two 50 nm diameter vesicles aggregate, their combined diameter would be doubled,
which RH determinations would reflect. However, there is one other factor that might affect the
size measurements. If two (or more) are aggregated, it is likely that the spherical approximation
of their shape cannot be made. Since the Stokes-Einstein equation is a spherical approximation,
RH results may be less precise or even difficult to obtain in general. Furthermore, an experimental
study that monitors the change, if any, in RH measurements over time could be beneficial in
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Figure 5.1: Preliminary results from a proof-of-concept vesicle fusion experiment. TDA was
performed on rhodamine-labeled vesicles before (A) and after (B) the addition of streptavidin. The
peaks shown are the raw data fits from each detector, normalized and overlaid.
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distinguishing between fusion and aggregation, as fusion occurs at a faster rate (nanoseconds [1])
than aggregation (up to days [2]). Additionally, a standard addition calibration of the number
of equivalents of streptavidin relative to the number of vesicles could be made. For instance,
varying molar ratios of streptavidin to biotinylated lipids can be added to the vesicle sample and
TDA performed to produce a plot of average RH versus molar ratio of streptavidin added. With
increasing molar ratios of streptavidin to biotinylated lipid, the average RH should also increase
until the amount of streptavidin is in excess, where the plot would plateau. If RH results can predict
the series of fusions (i.e. 1+1 up to 1+1+1+1) with increasing amounts of added streptavidin, it
can be hypothesized that fusion is occuring over aggregation. Non-spherical aggregates would
likely have less precise predictions. Predicting the number of vesicles that have fused may lead
to additional challenges, as it is possible that the system may contain a mixed population of the
number of fused vesicles, or even bound biotin per avidin protein. TDA can be coupled inline
to separation modes, such as CE, to resolve these populations. Nonetheless, plenty of potential
studies and experiments are possible and necessary to make determinations of the state of our
assay.

In regards to our initial model system, if the proposed experiments confirm that the increased
fluorescence signal observed when EMs, RVs, and streptavidin are mixed is due to vesicle fusion,
then future experiments could be performed to complete the vesicle fusion assay with molecular
recognition of exosome biomarkers.

Here, synthetic vesicles would be functionalized with

CD63/CD9/CD81 antibodies, combined with commercially purified exosomes, and the exosomes
assayed by proximity vesicle fusion, demonstrating the application of the proximity vesicle fusion
assay to characterizing exosome contents.

5.3

3D printed LIF detection TDA instrument

Chapter 4 describes the development of a 3D printed instrument for performing TDA in fused silica
capillaries with the detection sensitivity of laser-induced fluorescence. A low-cost, 3D printed,
eductor-based pressure system was developed and shown to produce nL min−1 flow rates with a 30fold improvement in stability of static pressure (0.05% RSD) as compared to a common mechanical
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pump (1.53% RSD). The instrument was found to have a detection limits of 15 nM, 80 pM, 1
nM, and 5 nM with Rhodamine 6G, R-Phycoerythrin, AlexaFluor 532, and CF532, respectively.
Quantitative performance was characterized with R-Phycoerythrin and a TDA demonstration was
performed.

5.3.1

Future work

Future directions include small modifications to the 3D print design of the instrument. The
current instrument design involves a mirror and ball lens for emission collection from the capillary
detection point. The curved mirror collimates light that is reflected in the opposite direction in
which it originated. A small percentage of this light, directed toward the detector, is partially
obstructed by part of the print engineered to hold the ball lens and by the capillary. The ratio of
focal length to lens diameter is termed f-number and given by the equation

f /# =

f
D

(5.3)

where f is the focal length and D is the lens diameter. F-number can be related to numerical
aperture (NA) by the following approximation

NA ≈

1
2f /#

(5.4)

Though focal length will decrease as the diameter of the ball lens decreases, the numerical aperture
will remain the same. By incorporating a smaller diameter ball lens (1 - 2 mm) (Fig. 5.2), we could
further limit the amount of light that is obstructed while collecting the same amount of light.

5.4

TDA-immunoassay

Our developed 3D printed instrument for performing TDA with high sensitivity via LIF detection
could be used in a variety of applications. Ultimately, the future work outlined in Section 5.1
would allow us to re-evaluate the condition of our originally proposed proximity vesicle fusion
assay. Additionally, there are other approaches to exosome characterization that can be made, such
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Figure 5.2: AutoCAD design comparison of 6 mm diameter ball lens holder (left) to 1 - 2
mm diameter ball lens holder (right). This illustrates the difference in obstruction of reflected,
collimated emission light from the mirror towards the detector.

121

as a TDA-immunoassay (TDA-IA) as described in Chapter 1.4.4.2.

5.4.1

Preliminary results

A proof-of-concept experiment was performed with purified human preadipocyte exosomes (ZenBio, Inc., Research Triangle Park, NC) and a FITC-labeled CD9 mouse monoclonal antibody
(Fisher Scientific). The experimental setup involved a looped 50 µm i.d. capillary so that two
detection windows lined up on an inverted epifluorescence microscope (Eclipse Ti-U, Nikon,
Newton, NJ), equipped with an LED excitation source (DC2200, Thorlabs, Newton, NJ), and
photon counting PMT (H7828-50, Hamamatsu, Hamamatsu, Japan). Changes in fluorescence
intensity were collected via LabView (National Instruments, Austin, TX). A 482 ± 9 nm LED
excitation filter, and 520 ± 12 nm emission filter was used for excitation and emission of FITCconjugated fluorophores. The low pressure driven flow rates necessary for TDA were achieved
with a U-tube. Here, the U-tube was filled with ethylene glycol and fitted with a 3-way connection
valve and tubing leading to the capillary outlet. Removal of the ethylene glycol from one leg of
the U-tube generates a differential pressure between both legs, based on the difference in height,
and produces a vacuum in the opposite leg from which the liquid was removed. This vacuum is
responsible for the low pressure driven flow within the capillary. The vacuum pressure (in psi) was
converted to volumetric flow rate within the capillary via a simple calibration experiment. Thus,
experimental flow rates could be estimated based on the volume of liquid removed from the U-tube
for a TDA experiment.

TDA was first performed on the CD9 antibodies to obtain a diffusion coefficient of 63.73 ±
9 µm2 s−1 and corresponding hydrodynamic radius of 3.9 ± 0.6 nm. Antibodies were mixed with
purified exosomes and TDA was performed to obtain a diffusion coefficient of 7.4 ± 1 µm2 s−1
and corresponding hydrodynamic radius of 33.8 ± 5 nm. A comparison of the band broadening
between detection windows for the pure antibodies (solid lines) and antibody-exosome mixture
(dashed lines) are given in Fig. 5.3. Peaks from both detection windows are normalized and
overlaid to illustrate band broadening, and both data sets are plotted side-by-side to illustrate the
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difference in band broadening between the antibodies and antibody-exosome complex.

The increase in RH between the pure antibodies and antibody-exosome mixture is indicative
of antibody binding to the CD9 membrane protein on the exosomes.

5.4.2

Future work

Future work following the proof-of-concept experiment described above would involve using these
size-based measurements to develop a complete and working immunoassay. A standard protocol
would be to first perform TDA on the labeled antibodies alone, with a hydrodynamic radius (RH ) of
5 – 6 nm. Next, the antibodies are added to a sample of purified exosomes (RH = 25 – 50 nm) and
TDA is performed. Since the antibodies are now bound to the surface proteins of the exosomes,
the measured RH will correspond to the complex. Furthermore, TDA provides an average RH
for the entire sample, so the determined RH for the mixture will lie between 25 – 50 nm, so
long as all of the antibodies are bound. A complete development of the TDA-IA would involve
the creation of a standard addition calibration representing a fraction of bound exosomes. When
the concentration of exosomes is zero, we should expect the measured average RH to be 5 – 6 nm,
corresponding to the size of the antibody alone. When the concentration of exosomes is equal to the
concentration of antibodies, we should expect an RH measurement of 25 – 50 nm, corresponding
to the size of the antibody-exosome complex. When the concentration of exosomes is less than the
concentration of antibodies, we would expect the measured RH to lie somewhere in between (5 –
50 nm), corresponding the average radius of bound and unbound antibodies. Such calibration plot
is necessary to determine some degree of quantitation of the CD9 membrane protein present in the
exosome sample, based on the fraction of bound exosomes. Future experiments could be modified
to target other potential exosomal membrane or surface proteins, such as CD63 or CD81.
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Figure 5.3: Preliminary data of TDA performed on CD9 antibodies (left) and antibody-exosome
mixture (right). Peaks are normalized and overlaid to represent band broadening between both
detection windows.
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A

Additional Materials for Chapter 3

The printing rights submitted as an attachment to this dissertation are meant to accompany
the article in Chapter 3, originally published in Analytical Methods by Meagan R. Moser and
Christopher A. Baker.
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B

Additional Materials for Chapter 4

The following figures and table are meant to accompany the article in chapter 4, originally
published in the Electronic Supplementary Information by Meagan R. Moser, Claire M. Smith,
and Christopher A. Baker. Only minor modifications were made.

”A 3D Printed Instrument for Taylor Dispersion Analysis with Two-point Laser-induced Fluorescence Detection” Submitted, 2021
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Figure B.1: Capillary cartridge and alignment tool. From left to right: 10 cm, 15 cm, and 20
cm window spacing cartridge. Middle cartridge illustrates use of alignment tool for window and
capillary end markings (red arrows), secured with the 3D printed key (red box).
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Figure B.2: Photograph of mounted capillary tubing sleeves (green) used to laterally hold the
capillary in place. Sleeves fit on either side of the detection window on the capillary. The 3D print
design was modified to tightly secure the tubing sleeves.
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Figure B.3: Selection of neutral density filter. OD 0.9 provided the highest S/N value among the
conditions observed. Further optimizations and experiments were performed using the OD 0.9
filter.
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Figure B.4: Flow rate calibration for 100 µm i.d. capillary with 15 cm window spacing.
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